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ABSTRACT

Role of Members of the Phosducin Gene
Family in Protein Translation
and Folding

Nana Kwasi Sono-Koree
Department of Chemistry and Biochemistry
Doctor of Philosophy
G proteins regulate various physiological processes by way of transducing a wide
variety of signals ranging from hormonal to sensory stimuli. Malfunctions in G
protein signaling lead to numerous diseases. G protein signaling begins with binding
of a ligand to a G protein-coupled receptor resulting in a conformational change that
leads to the exchange of a GDP for a GTP on G. The GTP bound  subunit
dissociates for its stable G dimer partner. G-GTP and G control the activity of
effector enzymes and ion channels that ultimately orchestrate the cellular response to
stimulus. Current reports have shown phosducin-like protein (PhLP1) as a cochaperone with the chaperonin-containing tailless complex polypeptide-1 (CCT) in
the assembly of G dimer. However, the studies did not address the role of PhLP1
and CCT in the translation and eventual assembly of G dimer. The data presented
in Chapter 2 shows a co-translational assembly of Gdimer regulated by PhLP1 and
CCT.

Chapter 3 discusses the role of PhLP2A and PhLP3 in CCT-mediated
assembly of actin and tubulin in mammalian cells. PhLP2 and PhLP3 are members of
the phosducin gene family that interact with CCT. Several studies in yeast suggest
that PhLP2 promotes CCT-dependent -actin folding while PhLP3 enhances tubulin folding. However, human PhLP2 has been shown to inhibit -actin folding,
indicating that PhLP2 and possibly PhLP3 have very different functions in humans
than they do in yeast. As a result, this study investigates in depth the role of PhLP2
and PhLP3 in CCT-dependent -actin and -tubulin folding in human cells.
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CHAPTER 1
Protein Translation and Regulation
The human genome is made up of about 25,000 genes (Pennisi, 2003), each
coding for a specific protein. The genetic information encoded is transcribed into
mRNA which is subsequently translated into protein. The fact that proteins are the
building blocks of life makes their synthesis central to cellular function, hence the
need for proper control of protein translation and subsequent folding into their native
three dimensional conformations.
Translation is the process by which genetic information contained in a
messenger RNA (mRNA) is decoded and converted into a protein. The process takes
place on large ribonucleoprotein complexes called ribosomes (Muckenthaler and
Preiss, 2006). Translation is divided into three steps namely: initiation, elongation and
termination. Translation initiation in eukaryotes begins with the formation of a preinitiation complex which includes the 40S ribosomal complex and its associated
factors at the 5' end of the messenger RNA (mRNA). The pre-initiation complex
scans the mRNA until the AUG start codon is reached. The 60S ribosomal subunit
joins the complex to form an elongation competent 80S ribosome. The process of
translation initiation is shown in Figure 1-1 on the following page.
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The next step in the process is the elongation step which begins with an initial
aminoacylated tRNA at the peptidyl P-site of the ribosome. An activated tRNA
(aminoacylated tRNA) with the appropriate codon-anticodon pair binds to the A-site
of the 80S ribosome. A peptide bond is formed between the previous amino acid and
the newly arrived one. The resulting peptide is translocated from the A-site to the Psite leaving the A-site free for another activated tRNA to start another elongation
cycle.

Figure 1-1. Initiation of Translation in Eukaryotes
Depicted is a typical eukaryotic mRNA with the post-transcriptional end modifications, a 5’ cap structure
and a 3’ poly (A) tail. The protein-coding region is marked by start and stop codons. First, the eIF4F
complex consisting of eIF4E, eIF4G, and eIF4A binds to the cap structure. The interaction between PABP
and eIF4G leads to a pseudo-circularisation of the mRNA. The small ribosomal subunit (40S) is then
recruited to the mRNA together with the initiation factors eIF3, eIF2 and the initiator-tRNAmet. This socalled 43S-preinitiation complex then moves along the mRNA in a process termed ‘scanning’. The
codon/anticodon interaction identifies the AUG start codon. This leads to the release of initiation factors
and joining of the large (60S) ribosomal subunit. The formation of the complete 80S ribosome completes
the initiation process and polypeptide synthesis as directed by the open reading frame can begin
(Muckenthaler and Preiss, 2006).
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The final step in the process of polypeptide synthesis is the termination step
which occurs when a stop codon reaches the A-site of the 80S ribosome. Through the
assistance of a number of eukaryotic release factors (eRF1 & 3), the resulting
polypeptide is released from the ribosome (Muckenthaler and Preiss, 2006). The 80S
ribosome subsequently dissociates into its 40S and 60S as shown in Figure 1-2.

Figure 1-2. Schematic representation of the events of eukaryotic translation.
The initiation steps bring together the 40S and 60S ribosomal subunits, mRNA, and the initiator tRNA, which
is complexed to the amino acid methionine (Met). During elongation, amino acids are brought to the
polysome, and peptide bonds are formed between the amino acids. The sequence of amino acids in the
growing protein is directed by the sequence of nucleic acid codons in the mRNA. After the last peptide bond
of the protein has been made, one of the codons UAG, UGA, or UAA signals the termination of translation.
The ribosomal subunits and message can be reutilized (Gilbert, 2006).

Despite the fact that each of the three phases of translation can be under the
influence of a number of physiological and pathological processes, the initiation step
is the main target of a number of control mechanisms. Many biological processes
including cellular growth, embryonic development, and response to environmental
3

and biological cues rely heavily on translational control. Defects in translation or its
control can lead to a number of diseases such as cancer, tissue hypertrophy and
neurodegeneration (Proud, 2007). Translational control is one of the many means
used by cells to ensure a steady internal environment.
Control of translation could be global where most or all cellular mRNAs are
equally affected, or selective where specific mRNAs are affected (Sonenberg et al.,
2000). The activity of most translation initiation factors is essential to the regulation
of mRNA translation. The activity of these initiation factors depends on their
phosphorylation status which is regulated by kinases and phoshatases. These kinases
and phosphatases are regulated by two major signaling pathways namely: the
Ras/MAPK and the PI3-K/Akt/mTOR pathways. The Ras/MAPK pathway regulates
the phosphorylation of cap binding protein eIF4E while the PI3-K/Akt/mTOR
pathway regulates the phosphorylation of ribosomal protein S6, eIF4G and 4Ebinding protein (Muckenthaler and Preiss, 2006) . The phosphorylation status of these
translation initiation factors can either stimulate or repress translation. This is seen in
disease states such as cardiac hypertrophy which is characterized by inappropriate
stimulation of protein accumulation due to signal-induced phosphorylation of
translation factors and also under cellular stress conditions such as increase in
temperature or the lack of glucose where a general inhibition of translation occurs.
The translation of specific mRNAs can also be controlled by interactions
between secondary structures within the 5' UTR or 3' UTR and regulatory proteins.
An example of this is seen with the iron absorbing protein ferritin whose expression is
regulated by the level of intracellular iron. When the level of iron in the cell is low,
4

the iron regulatory proteins 1 or 2 (IRP-1 or IRP-2) bind to a secondary structure
within the 5' UTR region of the ferritin mRNA called the iron responsive element
(IRE). This RNA-protein interaction blocks translation initiation. On the other hand,
if the level of iron in the cell increases, the IRP proteins dissociate and translation of
ferritin is restored (Sonenberg et al., 2000). Another example of translational control
as a result of RNA-protein interaction is seen with 15-lipoxygenase (LOX). The 3'
UTR region contains a differentiation control element (DICE) that mediates
translation repression by binding with heteronuclear ribonuclear proteins (hnRNP) K
and E1. The RNA-protein interaction inhibits translation at the 60S subunit-joining
step (Muckenthaler and Preiss, 2006). Organisms are in constant interaction with a
rapidly changing environment which necessitates the use of regulatory tools.
Regulation of protein translation and folding is nature’s way of preserving
homeostasis so as to avoid disease states.
Protein Folding
A unique characteristic of most living systems is the ability of its component
molecules to assemble with precision. The ability of proteins to fold into their three
dimensional structure and form functional complexes with other proteins is an
example of such assembly. The fact that every protein in a cell has its unique
functions and can only perform such functions if it is correctly folded into its native
structure makes protein folding a key element of cellular function, and defects in the
folding process can lead to serious pathological conditions.
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Proteins are synthesized on ribosomes where genetic information transcribed
into a messenger RNA is translated into polypeptides. Protein folding can be cotranslational where it is initiated before the completion of synthesis in which the
nascent polypeptide is still attached to the ribosome (Hardesty and Kramer, 2001) or
after release from the ribosome where they are either folded in the cytoplasm or in
specialized compartments like the mitochondria or the endoplasmic reticulum (Bukau
and Horwich, 1998). Failure of proteins to fold correctly or to remain folded leads to
malfunctioning of living systems and disease states such as cystic fibrosis,
Alzheimer’s and Huntington’s disease (Thomas et al., 1995). To ensure that proteins
remain in their three dimensional native states, certain macromolecules called
molecular chaperones are present in all types of cells and cellular compartments.
These molecules ensure that the process of protein folding takes place efficiently by
reducing the probability of competing reactions (Dobson, 2003).
One of the unique ways adopted by nature to avoid diseases is the degradation
of misfolded proteins. In eukaryotes, since most of the proteins synthesized are
excreted to the extracellular environment which lacks molecular chaperones, it is
important that only correctly folded proteins are exported. These secreted proteins are
translocated into the endoplasmic reticulum where they are correctly folded before
export by a complex network of chaperones. These proteins undergo a quality–control
check before they are finally exported as shown in Figure 1-3 on the following page
(Hammond and Helenius, 1995). Misfolded proteins can form aggregates within cells
or in the extracellular space leading to pathological conditions such as Alzheimer’s
and Parkinson’s diseases (Dobson, 2001). There are several signaling pathways in
6

cells that are regulated by specific proteins. Misfolding or translation inhibition of
such proteins leads to inhibition of the signaling pathway and ultimately the specific
physiological response. One such signaling pathway is mediated by G proteins and is
the topic of this thesis.

Figure 1-3. Regulation of protein folding in the ER.
Many newly synthesized proteins are translocated into the ER, where they fold into their three-dimensional
structures with the help of a series of molecular chaperones and folding catalysts (not shown). Correctly folded
proteins are then transported to the Golgi complex and then delivered to the extracellular environment. However,
incorrectly folded proteins are detected by a quality-control mechanism and sent along another pathway (the
unfolded protein response) in which they are ubiquitinated and then degraded in the cytoplasm by proteasomes
(Dobson, 2003)

An intriguing class of oligomeric, high-molecular-weight chaperones with the
unique ability to fold some cytosolic proteins that cannot be folded by simpler
7

chaperone systems are called chaperonins (Frydman, 2001). This unique group of
chaperones consists of two-ring assemblies with a central cavity where substrate
polypeptides bind to reach their native state (Bukau and Horwich, 1998; Gutsche et
al., 1999). Prokaryotes utilize the class I chaperonin GroEL, whose ring assembly is
made up of seven identical subunits and requires a co-chaperone GroES, which caps
the central cavity creating a protected space for the substrate polypeptide to fold
(Horwich et al., 2009). Eukaryotes employ a class II chaperonin, CCT (chaperonecontaining TCP1, also called TRiC, TCP-1 ring complex) (Bukau and Horwich, 1998;
Gutsche et al., 1999), which is a hetero-oligomeric complex with eight unique yet
homologous subunits per ring (Valpuesta et al., 2002). Each subunit consist of three
domains with specific functions: an equatorial ATP-binding domain, an apical
domain that is involved in substrate binding, and a central hinge domain that enables
communication between the equatorial domain and the apical domain (Spiess et al.,
2004). CCT was initially proposed to fold only actin and tubulin, but many other
substrates have been discovered (Thulasiraman et al., 1999), including a class of
proteins containing WD 40 repeats, a 40 amino acid repeat ending in a tryptophanaspartic acid (WD) sequence. WD40 repeats with -propeller structures have been
identified through proteomic studies to interact with CCT (Gavin et al., 2002; Ho et
al., 2002). Many CCT substrates cannot be folded by other prokaryotic and
eukaryotic chaperones (Tian et al., 1995), making CCT essential for the folding of
proteins that regulate important physiological functions. Many of the CCT substrates
identified so far are subunits of either a homo- or hetero-oligomeric complex (Spiess
et al., 2004), and their folding and function is coupled to their incorporation into their
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higher-order assemblies (Dunn et al., 2001). CCT can bind co-translationally to
nascent polypeptides as they emerge from ribosomes (Frydman et al., 1994;
McCallum et al., 2000; Melville et al., 2003; Siegers et al., 2003). Binding to CCT
requires the assistance of upstream chaperones (Frydman, 2001) and just like GroEL,
CCT recognizes its substrates using its apical domain, but the exact location of the
binding sites within this domain is not defined (Frydman, 2001). As a result of the
sequence diversity in apical domains, an attractive hypothesis is that different
subunits recognize different types of motifs, including both polar and hydrophobicrecognition sites (Frydman et al., 1994). The apical domains of CCT are in an open
conformation that exposes the substrate-binding sites in the absence of ATP
(Frydman et al., 1992; Gao et al., 1992; Llorca et al., 1999b). Addition of ATP
induces formation of the closed lid, which confines the substrate in the central cavity
(Spiess et al., 2004). After release of the γ-phosphate, ADP-bound CCT reverts to its
open state (Melki and Cowan, 1994). Kinetic studies suggest that subunits of one ring
bind to ATP in a positively cooperative manner (Kafri and Horovitz, 2003; Kafri et
al., 2001) an indication of a concerted mode of action during lid closure. The fact
that CCT is linked to several pathological states such as sensory neuropathy (Lee et
al., 2003) and tumor causing mutations in the CCT binding sites of some of its
substrates such as the VHL tumor suppressor (Spiess et al., 2004) makes it a key
element in the regulation of cellular functions and subsequent physiological
processes. An important CCT substrate is the  subunit of the heterotrimeric G
protein (G) (Lukov et al., 2005). G is a WD40 repeat protein that forms a sevenbladed -propeller structure (Sondek et al., 1996; Wall et al., 1995) and plays a key
9

role in G protein mediated signal transduction. To understand the physiological
importance of G and its CCT-dependent folding, a brief overview of G protein
signaling is required.

Figure 1-4. Model of the structural changes undergone by CCT during its functional cycle.
The nucleotide-free, substrate-free structure (1) shows an open conformation of its apical domains,
which undergoes large structural changes upon ATP binding such that the cavity is closed (2). The
substrate-free structure is able to bind unfolded actin (3) and tubulin (5) molecules in a quasi-native
conformation. Binding of tubulin generates a more closed conformation of the apical domains than
observed without substrate or after actin binding. ATP binding to the CCT–α-actin (4) or CCT–βtubulin (6) complexes induces conformational changes of the chaperonin apical domains that seal
the cavity using their helical extensions. The more downward and inward distribution of the apical
domains in the CCT–β-tubulin complex compared with the CCT–α-actin complex is maintained
after ATP binding (Llorca et al., 2001).
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G Protein Signal Transduction and its Regulation
Most extracellular signals such as hormones, neurotransmitters and sensory
stimuli are relayed into cells through activated plasma membrane bound receptors. G
protein-coupled receptors (GPCRs) form the largest class of such receptors with
greater than 1% of the human genome dedicated to their synthesis (Takeda et al.,
2002). GPCRs have a membrane-spanning region comprised of seven helices that
activates G proteins upon ligand binding, leading to the transduction of signals to
several intracellular signaling pathways. These activated signals interact with each
other forming a network that regulates many components of the cell’s machinery such
as metabolic enzymes, ion channels, transporters and transcriptional regulators
(Neves et al., 2002). These cellular activities in turn regulate many systemic functions
such as gonadal development, learning and memory and general organismal
homeostasis. The physiological importance of GPCRs has been demonstrated with
knockout models showing pathological phenotypes related to the nervous, endocrine,
sensory and cardiovascular systems (Yang et al., 2002). Due to their physiological
importance, GPCRs are a major therapeutic target for most pharmaceutical companies
with annual sales of several billion dollars (Overington et al., 2006).
Heterotrimeric G proteins are guanine nucleotide binding proteins that interact
with the intracellular domain of GPCRs and connect receptors with effectors. In so
doing, they transduce extracellular signals from hormones, neurotransmitters,
chemokines and paracrines to intracellular effectors. G proteins consist of three
different subunits namely G, Gand G. Currently 16G, 5G and 12Ghuman
genes have been identified with the existence of several splice variants (Gudermann,
11

2006). Based on sequence homology of the G subunits, G proteins have been
classified into four families namely Gs, Gq/11, Gi/o and G12/13. G protein 
subunits have a Ras-like GTPase domain which is used for GTP hydrolysis and a
helical domain which buries the bound nucleotide in the protein core (Gudermann,
2006). Gs have the unique characteristic of being the only G protein subunit that
binds guanine nucleotides and that has the ability to hydrolyze bound GTP.
Among the Gsubunits, all but G5 share between 78-80% sequence
homology (Schwindinger and Robishaw, 2001). G5 shares about 55% sequence
homology with the others and contains an additional 13 amino acid residues at the Nterminus. It is only expressed in the retina and central nervous system (Watson et al.,
1994). As mentioned previously, G subunits are made up of seven WD40 repeating
sequence motifs that form distinct  sheets that make a seven bladed propeller
structure which is connected by a loop to a 25 residue N-terminal -helix (Lambright
et al., 1996; Sondek et al., 1996).
G subunits are more structurally diverse compared to G. They share
between 27-76% sequence homology and all undergo posttranslational modification
of a carboxyl terminal cysteine residue in a conserved CaaX motif by an isoprenyl
group. This modification is essential for association of the G heterodimer with
membranes. G binds to G in an extended conformation devoid of intrachain tertiary
interactions (Gudermann, 2006). Even though G is a stable heterodimer, not all
combinations of G and G subtypes can form dimers (Mende et al., 1995).
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Figure 1-5. G proteins and Second Messengers.
When activated by agonists, G-protein-coupled receptors (GPCRs) profoundly change the
conformation of their transmembrane α-helices, which uncovers previously masked G protein
binding sites. This, in turn, promotes GDP-GTP exchange on the α-subunit, which results in their
activation. Consequently, Gβγ and GTP-bound Gα proteins stimulate effector molecules. The
biochemical changes that are induced are highly dependent on the individual receptor-coupling
specificity for each of the four families of mammalian G-protein α-subunits: αs, αi, αq or α12/13
(see Figure). Receptors that are coupled to Gαs activate adenylyl cyclases, thereby increasing
cyclic-AMP levels; whereas those that stimulate the Gαi-family members inhibit adenylyl
cyclases and reduce cAMP levels, as well as activating phospholipases and phosphodiesterases.
Receptors that are coupled to the Gαq family promote the activation of phosphatidylinositolspecific phospholipases, such as phospholipase C-β (PLCβ), which hydrolyses
phosphatidylinositol-4, 5-bisphosphate to generate inositol triphosphate (IP3) and diacylglycerol
(DAG). These elevate intracellular calcium concentrations and induce the activation of several
protein kinases, including protein kinase C (PKC) (Sodhi et al., 2004).
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It is not clear what determines selectivity even though the N terminus of G is
important for dimerization (Lupas et al., 1992). G1-4 can form irreversible dimers
with most G subunits (Dingus et al., 2005). In contrast, G5 only forms dimers
with RGS proteins of the R7 family (Witherow and Slepak, 2003).
G protein signaling is initiated when a ligand (agonist) binds to the
extracellular domain of a GPCR resulting in the exchange of a GDP for a GTP on the
inactive Gsubunit bound to G protein  dimer. The binding of GTP to G induces
conformational changes in three flexible switch regions resulting in its dissociation
from G dimer. Both the activated G-GTP and the G dimer relay signals to
downstream effectors including ion channels, adenylyl cyclase, phosphodiesterases
and phospholipases which give rise to changes in several second messengers that
regulate many physiological processes (Offermanns, 2003). Deactivation of G protein
signaling is caused by the intrinsic hydrolysis of GTP to GDP by G, a process that is
enhanced by members of the Regulators of G protein signaling (RGS) super family
(Koelle, 1997). Figure 1-5 is a depiction of G protein signal transduction when a
GPCR is either activated or deactivated.
G protein signaling is highly regulated either by controlling the number and
activity of GPCRs on the cell surface or through the hydrolysis of GTP by members
of the RGS family of proteins. The number and activity of GPCRs are controlled by
downstream effector kinases such as protein kinase A or C or by G protein receptor
kinases (GRK) (Gainetdinov et al., 2004). Phosphorylation by these kinases leads to
14

receptor deactivation. In the case of GRK, phosphorylation leads to the binding of
arrestin, which in turn recruits a clathrin adaptor protein (AP2) leading to the
inclusion of the GPCR into a clathrin-coated pit and final internalization into
endocytotic vesicles (Luttrell and Lefkowitz, 2002). The resulting vesicles are either
sent to the lysosomes where they are degraded, or they are recycled back to the cell
membrane.
Regulation of G protein signaling has also been proposed by G dimer
binding partners such as phosducin and PhLP1 that obstruct the dimer from activating
downstream effectors as a result of their interaction. However, more recent evidence
suggests that members of the phosducin family are not inhibitors of Gγ signaling but
rather they are essential co-chaperones with the cytosolic chaperonin complex (CCT)
to fold and assemble Gγ dimers (Willardson and Howlett, 2007).
The Phosducin Family
The phosducin family consist of three subgroups namely phosducin-I,
phosducin-II and phosducin-III based on phylogenetic analysis of 33 protein
sequences from mammals, invertebrates, plants and eukaryotes (Blaauw et al., 2003).
Members of each subgroup share extensive sequence homology at their C-terminal
thioredoxin-like domains while the N-terminal domains are very divergent. Figure 16 shows the phosducin family tree. PhLP1 is a 34kDa member of the phosducin gene
family that was initially discovered as an ethanol-induced gene in cultured neurons
(Miles et al., 1993). It shares 65% sequence homology with phosducin, and the two
constitute subgroup I of this gene family (Miles et al., 1993). PhLP1 is
15

expressed significantly in most tissues (Schroder and Lohse, 2000) and was initially
thought to inhibit G protein signaling by sequestering G and blocking its
interaction with effectors and G (Thibault et al., 1997). This sequestration
hypothesis for phosducin and
PhLP1 persisted for many years,
but was brought into question by
several inconsistencies, beginning
with the low expression level of
PhLP1 compared to G. In order
to block Gγ signaling in the cell,
PhLP1 had to be over-expressed to
well above the endogenous level
(McLaughlin et al., 2002a). In
addition, the deletion of the
Figure 1-6. The Phosducin Family Tree.
The phosducin family consists of three defined
subgroups. The protein sequences of 33 phosducin
homologues were obtained from different
organisms and aligned. The alignment was used as
input for the Phylip program to construct the
phylogenetic tree. The numbers indicate bootstrap
values (Blaauw et al., 2003).

phlp1gene in chestnut blight
fungus Cryphonectria parasitica
(Kasahara et al., 2000) and D.
discoideum (Blaauw et al., 2003)

resulted in a severe loss of G protein signaling, yielding the same phenotype as a G
gene deletion. This result was the opposite of what would be expected if PhLP1
down regulated G protein signaling. These inconsistencies led to further studies in
which PhLP1 was found to be an essential chaperone of Gγ dimer assembly instead
of an inhibitor of Gγ signaling as initially proposed (Lukov et al., 2005).
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The first evidence of the chaperone function of PhLP1 was the discovery of a
high affinity interaction between PhLP1 and CCT (McLaughlin et al., 2002a).
Importantly, PhLP1 was shown to be an interacting partner instead of a folding
substrate for CCT (McLaughlin et al., 2002a). Through cryo-electron microscopy,
PhLP1 was shown to bind to the apical domain of CCT subunits above the folding
cavity in a manner similar to the CCT co-chaperone prefoldin (Martin-Benito et al.,
2004). Several subsequent studies showed that PhLP1 and CCT acted as cochaperones in the assembly of the G dimer. First siRNA–mediated deletion of
PhLP1 in mammalian cells significantly decreased G1 expression and subsequent G
protein signaling with no effect on G1 mRNA levels (Lukov et al., 2005). Second,
pulse chase experiments measuring the rate of assembly of G12 showed a 5-fold
decrease when the cells were depleted of 90% of their PhLP1 and a 4-fold increase
when PhLP1 was over-expressed (Lukov et al., 2005). A similar observation was seen
in Dictyostelium where PhLP1 deletion resulted in cells completely devoid of
Gdimers (Knol et al., 2005). In addition, in vitro studies showed that nascent G
interacted with CCT (Wells et al., 2006). Together, these studies suggest that PhLP1
and CCT work together as partners to fold and assemble Gwith its heterodimer
partner G.
The proposed mechanism by which PhLP1 and CCT assist in G assembly is
shown in Figure 1-7. It begins with nascent G binding to CCT, followed by PhLP1
binding to form a ternary complex. This ternary complex is stable unless PhLP1 is
phosphorylated within serines 18-20 (Lukov et al., 2006; Lukov et al., 2005). Upon
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phosphorylation, a PhLP1-G complex dissociates from CCT and subsequently
associates with G, forming a PhLP1-G complex with a 100 nM binding affinity
(Savage et al., 2000). It is believed that the resulting dissociation is due to
electrostatic repulsion between the negatively charged phosphate moiety and negative
charges on the CCT apical domains. In this manner, CCT and PhLP1 enhance G
protein signaling by helping to assemble the G heterodimer, which plays an
essential role in the interaction of G with receptors and in the regulation of many
downstream effectors.
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Figure 1-7. Phosphorylation-dependent assembly of the Gγ heterodimer by CCT and PhLP1
According to the above model, nascent G initially binds to CCT, followed by PhLP1 binding. If PhLP1 is
phosphorylated at positions S18-20, depicted by a red oval, PhLP1-G is released and associates with Gγ to form
the heterodimer.
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In addition to its role as a co chaperone for the assembly of G heterodimer,
PhLP1 has been shown through bioluminescent energy transfer (BRET) studies to
interact with an endoplasmic reticulum-bound protein called DRiP78 which has been
proposed to stabilze G until it finds its stable interacting partner G (Dupre et al.,
2007a).
DRiP78 in G protein Signaling
DRiP78 is an endoplasmic reticulum-bound protein known for its transport of
seven transmembrane receptors with an FXXXFXXXF motif in their C-terminal tail
to the plasma membrane (Dupre et al., 2007a). DRiP78 contains two centrally located
transmembrane domains with cytosolic orientation of both its N and C termini
(Bermak and Zhou, 2001) and a 70 amino acid J domain which is near the N terminus
on the cytosolic surface of the endoplasmic reticulum (Qiu et al., 2006). It is proposed
that DRiP78 initially co-localizes with G before G dimer formation (Dupre et al.,
2007a). In the presence of G, G no longer interacts with DRiP78, suggesting that
DRiP78 releases G for interaction with G (Dupre et al., 2007a). Moreover, the
binding of PhLP1 to DRiP78 suggests that PhLP1 may bring the Gsubunit to
DRiP78 where it can bind Gγ and form the Gγ dimer (Dupre et al., 2007a).
Interestingly, the assembly of G dimers is reduced when DRiP78 level is reduced
using shRNA in HEK293 cells (Dupre et al., 2007a) an affirmation of the above
suggestion. There appears to be some specificity in DRiP78 interactions with
Gsubunits, preferring G2 and G3 which are both in Gγ subfamily II and are very
homologous at the sequence level (Dupre et al., 2007a)
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PhLP2- A CCT-dependent protein folding interacting partner
PhLP2 is one of the Phosducin-like genes found in the genomes of many
eukaryotes including mouse, humans, yeast, zebra fish and fly. Deletion of PhLP2 in
yeast is lethal as spore products that formed failed to grow (Flanary et al., 2000). In
D. discoideum, PhLP2 disruption led to a decrease in growth rate and subsequent
collapse of cultured cells after 16-17 cell divisions (Blaauw et al., 2003). There are
two PhLP2 genes in the genomes of mammals such as humans and mice. These two
share about 57% sequence homology (over 239 residues) and are called PhLP2A and
PhLP2B (Wilkinson et al., 2004). While PhLP2A is ubiquitously expressed, PhLP2B
is only expressed in male and female germ cells undergoing meiotic maturation
(Lopez et al., 2003). Through confocal microscopy studies, PhLP2A was shown to be
localized in the cytoplasm (Wilkinson et al., 2004). Just like PhLP1, PhLP2 interacts
with the cytosolic chaperone containing tailless complex (CCT) as a folding partner
and not as a substrate (Stirling et al., 2007). PhLP2 has been suggested as a possible
CCT co-chaperone in the folding of components essential for regulating cell cycle
progression (Stirling et al., 2007), but the identity of these components has not be
determined.
Studies of temperature-sensitive mutants of PhLP2 in yeast suggest a possible
role of PhLP2 with CCT in the folding of cytoskeletal proteins actin and tubulin
(Stirling et al., 2007). However, in vitro studies showed that PhLP2A formed an
inactive ternary complex with CCT that inhibited actin folding (Stirling et al., 2007).
In contrast, subsequent in vitro studies showed that yeast PhLP2 enhanced actin
folding by CCT by seven fold over the basal level (McCormack et al., 2009). Thus,
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most of the evidence indicates that PhLP2 is a co-chaperone for actin folding in yeast.
PhLP2A could also be involved in the folding of proapoptotic factors due to complete
inhibition of caspase-3 processing following the initiation of Bax-induced
programmed cell death in PhLP2A siRNA knockdown cells (Wilkinson et al., 2004).
PhLP3 - A CCT interacting partner involved in the folding of -tubulin and
other CCT substrates
PhLP3, which is also called APACD or TXNDC9 in mammals, interacts with
CCT just like PhLP1 and PhLP2 (Stirling et al., 2006). Cryo-EM studies have shown
that PhLP3 and CCT form a complex (Stirling et al., 2006). PhLP3 has been linked
to G protein signaling in yeast (Flanary et al., 2000), but has also been implicated in
tubulin function in yeast and C. elegans (Stirling et al., 2006). Unlike PhLP2, PhLP3
deletion had no obvious phenotypic effect in D. discoideum (Blaauw et al., 2003). As
with PhLP2, there are discrepancies between the role of PhLP3 through in vivo and in
vitro studies. While in vivo genetic studies suggest PhLP3 as an enhancer of -tubulin
folding (Lacefield and Solomon, 2003), in vitro studies suggest otherwise (Stirling et
al., 2006). Yeast studies of PhLP3 suggest it may be a down regulator for the
expression and folding of actin, a notion that is supported by in vitro studies (Stirling
et al., 2006). However the exact role of PhLP3 in actin folding is not clearly defined.
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CHAPTER 2
CO-TRANSLATION ASSEMBLY OF THE G PROTEIN DIMER
Summary
Current reports have shown phosducin-like protein (PhLP1) to be a cochaperone with the cytosolic chaperonin complex CCT in the assembly of G dimer.
However, the studies did not address the role of PhLP1 and CCT in the translation
and eventual assembly of G dimer. This work outlines an elegant mechanism that
links translation of the Gγ subunit to formation of the Gγ dimer, bringing together
the unstable G and Gγ polypeptide chains in a way that avoids aggregation or
degradation of the Gγ subunit.
Introduction
G proteins function as molecular switches, relaying signaling information
from G protein-coupled receptors (GPCR) at the cell’s extracellular surface to
effector enzymes and ion channels on the cytoplasmic side of the plasma membrane.
The signaling pathway is initiated by the binding of a ligand to the extracellular
domain of the receptor which induces a conformational change that opens up the
cytoplasmic side of the seven transmembrane helical bundle found in all GPCRs.
This conformational change exposes an interaction site for the C-terminus of the G
protein  subunit (G) (Farrens et al., 1996; Kobilka and Deupi, 2007; Scheerer et
al., 2008); and the resulting binding of the receptor to G causes a conformational
change in G that drives exchange of GDP for GTP in its guanine nucleotide binding
pocket (Oldham and Hamm, 2008). GTP binding results in a rearrangement of the
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interface between Gand the G dimer of the G protein heterotrimer, releasing both
G-GTP and G for interactions with effectors (Preininger and Hamm, 2004;
Sprang, 1997). By controlling effector activity, G proteins orchestrate cellular
responses via changes in the concentration of important second messengers such as
cyclic nucleotides, Ca2+ and phosphatidyl inositol lipids (Arshavsky et al., 2002; Drin
and Scarlata, 2007; Hanoune and Defer, 2001; Hawkins and Stephens, 2007), by
regulating membrane potential through K+ and Ca2+ channels (Tedford and Zamponi,
2006; Xie et al., 2007), or by activating actin cytoskeleton rearrangements through
nucleotide exchange factors for Rho GTPases (Worzfeld et al., 2008). Through these
signaling pathways, G proteins regulate many important physiological processes, the
malfunction of which results in numerous diseases ranging from heart failure (Pleger
et al., 2007) to metastatic cancer (Juneja and Casey, 2009)
In order to perform its essential function, the G protein heterotrimer must be
assembled post-translationally from its individual components. This is not a trivial
task given the instability of both the G and Gγ subunits prior to formation of the
Gγ dimer. This instability is overcome by a network of molecular chaperones that
escort both the nascent G and Gγ polypeptides until they are brought together to
form the stable Gγ complex. Recently, considerable progress has been made toward
understanding the mechanism of Gγ assembly. The G subunit is assisted in folding
into its seven-bladed -propeller structure by the cytosolic chaperonin containing
tailless complex polypeptide 1 (CCT, also called TCP1 ring complex (TRiC))
(Lukov et al., 2006; Lukov et al., 2005; Martin-Benito et al., 2004; McLaughlin et al.,
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2002a; Wells et al., 2006). CCT is a large oligomeric protein complex made up of
two rings of eight distinct but homologous subunits (Valpuesta et al., 2002). The two
rings stack against each other to form a cylindrical structure with a central cavity on
both ends, into which nascent polypeptides and unfolded proteins associate (Llorca et
al., 1999). Each CCT subunit has intrinsic ATPase activity and upon ATP binding, a
conformational change causes the tips of the CCT subunits to close over the protein
substrate, creating a protected space in which the protein can fold (Llorca et al.,
2001). Upon ATP hydrolysis, the folding cavity opens up and the folded protein,
which has lost contacts with CCT during the folding process, is released into the
cytosol (Llorca et al., 2001). Proteins identified as CCT substrates now number in the
hundreds (Dekker et al., 2008), with possibly 5-10% of all cytoplasmic proteins being
folded by CCT (Yam et al., 2008). Among CCT folding substrates, there is an
enrichment in proteins with complex -sheet structures as well as in polypeptides that
are part of oligomeric protein complexes (Yam et al., 2008). Thus, the G subunit is
a typical CCT folding substrate.
A unique aspect of CCT-dependent G folding is the inability of G to release
from CCT on its own, necessitating the co-chaperone phosducin-like protein 1
(PhLP1) to release G from CCT and mediate its assembly with Gγ (Lukov et al.,
2006). In this process, PhLP1 is believed to form a ternary complex with G and
CCT, with G in the folding cavity and PhLP1 positioned above the cavity,
contacting both G and the tips of the CCT subunits (Lukov et al., 2006; MartínBenito et al., 2004). Once G is folded, it is released from CCT, possibly as a
24

PhLP1-G intermediate (Lukov et al., 2006; Lukov et al., 2005). In this intermediate,
the Gγ binding site on G is completely accessible (Gaudet et al., 1996), allowing Gγ
to associate with G. Gγ itself is also believed to require chaperones. This small 70
amino acid polypeptide does not form a stable structure in the absence of G, but has
been shown to bind the J-domain containing chaperone DRiP78 prior to its assembly
with G (Dupre et al., 2007b). Interestingly, PhLP1 was also reported to interact with
DRiP78 (Dupre et al., 2007b), suggesting that the PhLP1-G complex may contact
DRiP78 and remove Gγ, forming the PhLP1-Gγ complex. This complex is stable
with a Kd of ~ 100 nM (Savage et al., 2000), but PhLP1 can dissociate from Gγ
through competition with G for the same binding site (Gaudet et al., 1999; Yoshida
et al., 1994). Once PhLP1 is released and the Gγ heterotrimer is formed, it can be
trafficked to the plasma membrane to interact with GPCRs and perform its signaling
function (Marrari et al., 2007).
Interestingly, in experiments where PhLP1 function was inhibited by siRNAmediated depletion or by over-expression of a dominant negative PhLP1 variant, not
only was the rate of Gγ assembly severely inhibited, but the synthesis of both
nascent G and Gγ appeared to be decreased as well (Lukov et al., 2005). This
decrease did not seem to be simply a result of rapid degradation of the undimerized
G or Gγ, but rather from a possible negative feedback mechanism in which the
synthesis of G and Gγ was down-regulated by the inability of the subunits to form
dimers (Lukov et al., 2005). The current study was initiated to further investigate this
observation. The results suggest that in the process of translation, the N-terminus of
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Gγ forms an initial coiled-coil interaction with G in the CCT folding cavity which
causes translation of the remaining Gγ to stall. PhLP1 relieves this inhibition by
releasing G from CCT, allowing Gγ to finish its translation and simultaneously form
the Gγ dimer. Thus, Gγ assembly appears to occur by an elegant co-translational
mechanism, obviating the need for a Gγ chaperone to bring the dimers together.
Experimental Procedures
Cell Culture - HEK293T cells were cultured in DMEM/F-12 (50/50 mix)

growth media supplemented with L-glutamine, 10% fetal bovine serum and 15 mM
HEPES (Hyclone Scientific). In order to maintain active growth, cells were
subcultured regularly but not beyond 15 passages.
Preparation of cDNA constructs - The pcDNA3.1 vectors containing N-

terminally Flag-tagged human Gβ1 and N-terminally HA-tagged Gγ2 were obtained
from the UMR cDNA Resource Center (www.cdna.org). Wild type human PhLP1
and the PhLP1 Δ1-75 N-terminal truncation variant each with a 3′ c-myc and His6 tag
were constructed in pcDNA3.1/myc-His B vector using PCR as described (Carter et
al., 2004; Lukov et al., 2005). The pcDNA3.1(+)-Flag-GST and pcDNA3.1(+)-Flag-actin constructs were created by PCR amplification of the GST and -actin cDNAs
(Open Biosystems) with the primers 5'- BamHI-Flag-GST , 5'-BamHI-Flag--actin,
3'-XhoI-GST and XhoI--actin, digestion with BamHI and XhoI, and ligation into
pcDNA3.1(+). The pcDNA3.1(+)-HA-Gγ-Flag-GST fusion construct was created by
PCR amplification of the HA-tagged Gγ gene from pcDNA3.1(+)-HA-Gγ vector with
the primers 5′-NheI-Gγ and 3′-KpnI-Gγ,digestion with NheI and KpnI, and ligation
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into pcDNA3.1(+)-Flag-GST. The pcDNA3.1(+)-HA-Gγ-10-Flag-GST,
pcDNA3.1(+)-HA-Gγ-20-Flag-GST, and pcDNA3.1(+)-HA-Gγ-30-Flag-GST fusion
constructs were also created by PCR amplification of the HA-tagged Gγ gene from
pcDNA3.1(+)-HA-Gγ with the forward primers 5′-NheI-Gγ-10, 5′-NheI-Gγ-20,
5′-NheI-Gγ-30 and the reverse primer 3′-KpnI-Gγ, digestion with NheI and KpnI, and
ligation into pcDNA3.1(+)-Flag-GST. The pcDNA3.1(+)-HA-Gγ-frameshift-FlagGST and pcDNA3.1(+)-HA-Gγ(L15/E, L19/E)-Flag-GST fusion constructs were
created by PCR amplification of the HA-tagged Gγ-10 gene from pcDNA3.1(+)-HAGγ-10-Flag-GST with the forward primers 5′-NheI-Gγ-10-fs, 5′-NheI-Gγ-10-L/E and
the reverse primer 3′-KpnI-G-gamma, digestion with NheI and KpnI, and ligation into
pcDNA3.1(+)-Flag-GST. The integrity of each construct was validated by automated
DNA sequencing and analysis. Table 1 provides the sequences of the primers used in
construction of these vectors.
5′-NheI-Gγ

TGGGTTGCTAGCATGTACCCATACGATGTTCCAGATTACGCT
G

5′-NheI-

TGGGTTGCTAGCATGTACCCATACGATGTTCCAGATTACGCT

Gγ-10

GCCAGGAAGCTGGTAGAGCAGCTTAAGATG

5′-NheI-Gγ

TGGGTTGCTAGCATGTACCCATACGATGTTCCAGATTACGCT

-20

GAAGCCAATATCGACAGGATAAAGGTGTCCAAGG

5′-NheI-

TGGGTTGCTAGCATGTACCCATACGATGTTCCAGATTACGCT

G-30

GCAGCTGCAGATTTGATGGCCTACTGTG
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5′-NheI-

GGTTGCTAGCATGTACCCATACGATGTTCCAGATTACGCTGG

Gγ-10-fs

CCAGGAAGCTGGTAGAGCAGCTAAAGATGAAGCCAATATCG
ACAGGATAAAGGTGTC

5′-NheI-

GGTTGCTAGCATGTACCCATACGATGTTCCAGATTACGCTCC

Gγ-10-L/E

AGGAAGGAAGTAGAGCAGGAAAAGATGGAAGCCAATATCG
ACAGGATAAAGG

3′-KpnI-Gγ

TGGGTTGGTACCAAGGATGGCACAGAAAAACTTCTTCTCCC
TAAACG

5’-BamHI-

AATTGGGGATCCATGGATTACAAGGATGACGACGATAAGCA

Flag-GST

GGCGGGGAAGCCCATCCTC

3’-XhoI-

AATGTGCTCGAGCTAGGCCCTCAGCTCAGTGGGTGTATCTG

GST

GCTGCCGGCAGGGGTGAGACACCTGGAA

5’-BamHI-

AATTGGGGATCCATGGATTACAAGGATGACGACGATAAGGA

Flag –-

TGATGATATCGCCGCGAATGTGCTCGAGTTACGTAGAATCG

actin

AGACCGAGGAGAGGGTTAGGGATAGGCTTACCGAAGCATTT
GCGGTGGACGATGGAGGGGCC
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RNA Interference – Small interfering RNAs (siRNAs) were chemically

synthesized (Dharmacon) to target nucleotides 345-365 of human PhLP1 (Lukov et
al., 2005) and nucleotides 865-883 of human G1 which are 100% conserved in G2
(Krumins and Gilman, 2006). All the oligonucleotides had 3′dTdT overhangs.
HEK293T cells were cultured in 12 well plates to 40-65% confluency. Cells were
then transfected with the appropriate siRNA at 100 nM final concentration using
Oligofectamine (Invitrogen) (Lukov et al., 2005). After 24 hours, the cells were
transfected with 0.5 μg of the indicated cDNAs in the pcDNA3.1 (+) vector using
Lipofectamine Plus reagent according to the manufacturer’s protocol (Invitrogen).
Cells were harvested for subsequent immunoprecipitation experiments 72 hours later.
To assess the percent knockdown of specific proteins, 15 μg of cell lysate were
immunoblotted with an anti-PhLP1antibody (Thulin et al., 1999) and anti-G1-4
antibodies (Lee et al., 2004).
Translation Rate Determination - Transfected HEK-293 cells in 12-well plates

were washed and incubated for 1 h in 1000 µl of methionine free media (Mediatech,
Inc) supplemented with 4 mM L-glutamine (Sigma), 0.063g/L L-cystine
dihydrochloride (USB) and 10% dialyzed fetal bovine serum (Invitrogen). The media
was discarded and 400 µl of new media supplemented with 200 µCi/ml radiolabeled
L-[35S] methionine (Amersham Biosciences) was added. Cells were incubated at 23oC
for 5, 10, 15, 25 and 35 min. to incorporate the [35S] methionine into the newly
synthesized proteins. After the pulse, the cells were washed and harvested for
subsequent immunoprecipitation experiments.
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For translation rate experiments involving the PhLP1 ∆1-75 dominant
interfering mutant (Lukov et al., 2005), HEK 293T cells were plated in 12-well plates
and grown to 70-80% confluency. The cells were then transfected using
Lipofectamine Plus reagent according to the manufacturers protocol (Invitrogen).
Wells were transfected with 1.0 μg each of either the empty vector control or PhLP1
Δ1-75-myc along with 1.0 μg each of either Flag-Gβ1 or HA-Gγ2 cDNAs. After 48
hrs, the cells were labeled with [35S] methionine and prepared for
immunoprecipitation as described below.
Immunoprecipitation -Transfected HEK 293T cells in 12-well plates were

washed with phosphate-buffered saline (PBS, Fisher) and solubilized in
immunoprecipitation buffer (PBS, pH 7.4, 0.5% NP-40 (Sigma), 0.6 mM PMSF, 6
μl/ml protease inhibitor cocktail per mL buffer (Sigma)). The lysates were passed
through a 25-gauge needle 10 times and centrifuged at 14,000 rpm for 10 min. at 4ºC
in an Eppendorf microfuge. The protein concentration for each sample was
determined using the Coomassie Plus Protein Assay reagent (Thermo Scientific) and
equal amounts of protein were used in the subsequent immunoprecipitations. 160 μg
of total protein from the clarified lysates were incubated for 30 min. at 4°C with 2 μg
anti-Flag (clone M2, Sigma) or anti-HA (clone 3F10, Roche) antibodies followed by
an additional 25 μl of a 50% slurry of Protein A/G Plus agarose (Santa Cruz
Biotechnology). The resulting mixture was incubated for 30 min. at 4°C as described
(Lukov et al., 2005). The immunoprecipitated proteins were solubilized in SDS
sample buffer and resolved on a 10 % Tris-glycine-SDS gel or a 16.5 % Tris-tricineSDS gel for Gγ. The gels were dried on Whatman filter paper for subsequent
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radioactivity measurements. Gels were visualized with a Storm 860 phosphor imager
and the band intensities were quantified using the Image Quant software (GE
Healthcare).
Quantitative RT-PCR - Total RNA was isolated using RNA-STAT60 (Tel-

Test, Friendswood, TX) according to the manufacturer’s protocol, except that
following precipitation of the RNA with isopropanol, the centrifugation time was
increased to 60 min. The resulting RNA preparation was treated with DNase I (DNAfree; Ambion, Inc., Austin, TX) to remove contaminating DNA. RNA from equal
numbers of cells was reverse-transcribed using a dT oligo (Invitrogen) and
SuperScript III reverse transcriptase (Invitrogen). The cDNA template was then used
for quantitative PCR (TaqMan) with the following primers and probe: human
GAPDH, GNG2 and GNB1 (Applied Biosystem). The quantitative PCR conditions
were as follows: 1 cycle at 50°C for 2 min and 1 cycle at 95°C for 10 min, followed
by 60 cycles at 95°C for 15 s and 60°C for 1 min. The cell equivalents were based on
GAPDH amplification.
Degradation Rate Determination - HEK-293T cells were treated with PhLP1

siRNA for 24 hrs and then transiently transfected with 0.5μg each of Flag-tagged G1
and/or HA-tagged G2 as indicated. After 72 additional hrs, the cells were pulsed
with 200 µCi/ml radiolabeled L-[35S] methionine (Amersham Biosciences) for 10 min
followed by washing and chasing for the indicated time periods with 1 ml of media
supplemented with 4 mM non-radiolabeled L-methionine (Sigma) and 4 µM of
cycloheximide to stop the methionine incorporation. Cells were then lysed with the
appropriate immunoprecipitation buffer (PBS, pH 7.4, 0.5% NP-40 (Sigma), 0.6 mM
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PMSF, 6 μl/ml protease inhibitor cocktail per mL buffer (Sigma)) and G or G2
was immunoprecipitated as described above. Immunoprecipitates were separated by
SDS-PAGE and radioactive bands were visualized and quantified on the phosphor
imager.
Assessment of G and G Aggregation - HEK-293 cells were treated with

PhLP1 siRNA for 24 hrs and then transiently transfected with 0.5 μg each of FlagG1 and HA-tagged G2. After 72 additional hrs, the cells were pulsed with 200
µCi/ml radiolabeled L-[35S] methionine (Amersham Biosciences) for 25 min. Cells
were then lysed with the appropriate immunoprecipitation buffer (PBS, pH 7.4, 0.5%
NP-40 (Sigma), 0.6 mM PMSF, 6 μl/ml protease inhibitor cocktail per mL buffer
(Sigma)) and Gor G was immunoprecipitated as described above. Pellets
obtained after centrifuging the lysed cells were resuspended in 0.5% SDS. Nascent
proteins from the suspended pellets, immunoprecipitates and supernatant of the
immunoprecipitate were separated by SDS-PAGE and radioactive bands were
visualized and quantified on the phosphor imager.
Polysome Association Measurement - 100 mm dishes containing HEK293T

cells were grown in Dulbecco’s Modified Eagle’s medium (Hyclone) supplemented
with 10% fetal bovine serum (Sigma) to 100% confluency. The cells were incubated
with or without 400 µM puromycin for 1 hr at 37oC after which the cells were
incubated with 100 µg/ml cycloheximide for 15 min. to stabilize translating
ribosomes (Raue et al., 2007). The cells were washed with 20 mM HEPES pH 7.5,
10 mM KCl, 1 mM EGTA, 5 mM MgCl, 10% glycerol, 2 mM -mercaptoethanol
(Hundley et al., 2005) and harvested in this same buffer + 0.2% NP-40 (Sigma). The
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resulting lysate was passed through a 25-gauge needle 10 times after which it was
centrifuged at 14,000 rpm for 10 min. at 4ºC in an Eppendorf microfuge to remove
cell debris. The supernatant was loaded onto a 10-70% sucrose gradient containing 20
mM HEPES pH 7.4, 100 mM KCl, 5 mM MgCl2 and 2 mM dithiothreitol and
centrifuged at 38,000 rpm for 4 hrs at 4oC in a Beckman SW41 rotor. After the
centrifugation, 500 µl fractions were collected and subjected to chloroform/methanol
precipitation to concentrate the proteins and remove the sucrose. The precipitated
proteins were solubilized in SDS-PAGE sample buffer and resolved on 10% TrisGlycine-SDS gels for G or 16.5% Tris-tricine gel for G. The proteins were
transferred to nitrocellulose and immunoblotted using an anti-CCTζ (Santa Cruz
Biotechnology), anti-PhLP1 antibody (Thulin et al., 1999), or an anti-RPL23 antibody
(Abgent). Immunoblots were incubated with the appropriate anti-rabbit, (Li-Cor
Biosciences), or anti-rat (Rockland) secondary antibody conjugated with an infrared
dye. Blots were scanned using an Odyssey Infrared Imaging System (Li-Cor
Biosciences), and protein band intensities were quantified using the Odyssey
software.
Results
In pulse/chase experiments designed to measure the effect of siRNAmediated PhLP1 knockdown on Gγ assembly, an ~50% decrease in the amount of
G and Gγ synthesized during the 10 min. pulse with [35S] methionine was
consistently observed (Lukov et al., 2005). To confirm and further characterize this
decrease, the effect of PhLP1 knockdown on the rate of G and Gγ synthesis was
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measured. HEK-293T cells were depleted of 80% of their endogenous PhLP1 (Fig.
2-1A) and were subsequently transfected with G and Gγ together or individually.

Figure 2-1. siRNA inhibition of PhLP1 and G1 expression.
HEK-293T cells were treated with an siRNA targeting nucleotides 345-365 of PhLP1 (A), nucleotides
865- 883 of G1/2 (B) or a scrambled control siRNA as indicated. After 96 hrs, the cells were lysed and
the extracts were immunoblotted for PhLP1 or G1. Blots were visualized and quantified using an
Odyssey Infrared Imaging System (LiCor Biosciences). Bars represent the average ± the standard error
from three experiments. Representative blots are shown below the graphs.

The rate of G and Gγ synthesis was then measured by [35S] methionine labeling for
increasing times, followed by immunoprecipitation of the nascent G and
quantification of the amounts synthesized at each time point. When G and Gγ were
co-expressed, the rate of Gγ synthesis was decreased 55% by PhLP1 depletion (Fig.
2-2A). A very similar 54% decrease was observed when Gγ was over-expressed in
the absence of G (Fig. 2-2B). The effects of PhLP1 depletion were less pronounced
in the case of G. When G and Gγ were co-expressed, the rate of G synthesis was
decreased by 37% (Fig. 2-2C), but was unchanged when G was expressed in the
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absence of Gγ (Fig. 2-2D). These results confirm the initial observations and reveal
important differences between the effects of PhLP1 depletion on G and Gγ
synthesis.

Figure 2-2. PhLP1 knockdown inhibits the rate of G synthesis.
HEK-293T cells were treated with or without PhLP1 siRNA for 24 hrs and then transiently
transfected with FLAG-tagged G1 and HA-tagged Gγ2 (A and C), HA-Gγ2 alone (B), or FLAGG1 alone (D). After 48 additional hrs, the cells were pulsed with 35S-methionine for the times
indicated, then lysed and immunoprecipitated with anti-HA for Gγ (A and B) or anti-FLAG for G
(C and D). Immunoprecipitates were separated by SDS-PAGE and radioactive Gγ or G bands were
visualized and quantified on a phosphor imager. Data points represent the average ± the standard
error from three experiments. Representative gels are shown below the graphs.
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The fact that PhLP1 depletion did not change the rate of G synthesis in the
absence of Gγ suggested that the effect was specific and not simply a result of double
stranded RNA-induced inhibition of overall translation (Hovanessian, 2007). To
further assess specificity, the rate of glutathione-S-transferase (GST) synthesis, when
expressed from the same expression vector as G and Gγ, was also tested with and
without PhLP1 siRNA and showed no difference (Fig.2-3A). In addition, the rate of
endogenous actin synthesis was also measured with and without PhLP1 siRNA and
again there was no change (Fig.2-3B). These results indicate that siRNA-mediated
PhLP1 depletion specifically inhibited Gγ synthesis without affecting protein
synthesis in general. Another way to disrupt Gγ dimer formation is through the
PhLP1∆1-75 truncation, which acts in a dominant negative manner to block Gγ
assembly. PhLP1∆1-75 competes with endogenous PhLP1 by forming a PhLP1∆175-G-CCT complex that does not release G to interact with Gγ (Lukov et al.,
2006; Lukov et al., 2005). The effect of this PhLP1 variant on the rate of Gγ and G
synthesis was also measured. Over-expression of PhLP1∆1-75 caused a 45%
reduction in Gγ synthesis whether co-expressed with G or not (Fig. 2-4A and B). In
contrast, G expression was only decreased 20% by PhLP1Δ1-75 when co-expressed
with Gγ (Fig. 2-4C) and there was no effect of PhLP1∆1-75 when G was expressed
in the absence of Gγ (Fig. 2-4D). These results confirm the siRNA results and further
indicate that when PhLP1 function is lost, there is a significant decrease in the rate of
Gγ synthesis and a modest decrease in G synthesis, but only in the presence of G.
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Figure 2-3. PhLP1 depletion has no effect on GST or actin synthesis.
HEK-293T cells were treated with or without PhLP1 siRNA for 24 hrs and then transiently transfected
with GST (A) or left untransfected (B). After 72 additional hrs, the cells were pulsed with 35Smethionine for the times indicated, then lysed and immunoprecipitated with anti-GST (A), or
endogenous nascent -actin was precipitated with anti-Flag (B). Precipitates were separated by SDSPAGE and radioactive GST or -actin bands were visualized and quantified on a phosphor imager.
Data points represent the average ± the standard error from three experiments. Representative gels are
shown below the graphs.

There are several ways in which the apparent rate of G and Gγ synthesis could be
decreased by PhLP1 depletion. An obvious way would be the rapid degradation of
the unassembled G and Gγ in the absence of PhLP1. This possibility was tested by
measuring the rate of G and Gγ degradation with and without PhLP1 siRNA in a
pulse-chase experimental format. Unexpectedly, there was no significant difference
in the rate of degradation of either G or Gγ under these conditions despite the fact
that PhLP1 depletion resulted in less G and Gγ synthesized during the pulse phase of
the experiment (Fig. 2-5A and B). All of the curves showed a degradation sensitive
fraction that decayed with t1/2 values in the 5-10 min range and leveled off after about
60 min., leaving a stable, degradation-resistant fraction. A second possible reason for
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the decreased rate of G and Gγ synthesis could be the increased degradation of their
mRNAs in the absence of PhLP1. This possibility seemed unlikely given that the
mRNAs were produced from expression vectors with non-native 5′ and 3′
untranslated regions (UTR) that normally carry the regulatory elements in native
mRNAs (Hentze et al., 2007). Accordingly, RT-PCR measurements showed no

Figure 2-4. PhLP1 ∆1-75 inhibits the rate of Gγ synthesis.
HEK-293T cells were transiently transfected with PhLP1 ∆1-75 along with FLAGG1 and HA-Gγ2 (A and C), or HA-Gγ2 alone (B), or FLAG-G1 alone (D). After
48 hrs, the cells were pulsed with 35S-methionine for the times indicated, then lysed
and immunoprecipitated with anti-HA for Gγ (A and B) or anti-FLAG for G (C and
D). Immunoprecipitates were separated by SDS-PAGE and radioactive Gγ or G
bands were visualized and quantified on a phosphor imager. Data points represent
the average ± the standard error from three experiments. Representative gels are
shown below the graphs.
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difference in G or Gγ mRNA in the presence or absence of PhLP1 siRNA,
confirming that mRNA levels of G and Gγ do not change in the absence of PhLP1
(Fig. 2-6).
Finally, it is possible that the decrease in G and Gγ synthesis upon PhLP1
depletion could be caused by aggregation of the newly synthesized proteins into
insoluble aggregates that are lost during the immunoprecipitation process. This
possibility was tested by assessing the amount of 35S-labeled G and Gγ in each
immunoprecipitation fraction by SDS-PAGE. If the nascent proteins were forming
insoluble aggregates, they would be found in the pellet after centrifugation of the
initial cell extract. However, no G or Gγ was found in this pellet or in the
supernatant after immunoprecipitation, but only in the immunoprecipitate itself in
both depleted or control cells, indicating that no aggregation was occurring (Fig. 2-5
C and D). This process of elimination leads to the unexpected conclusion that the
loss of PhLP1 function somehow causes a decrease in the rate of translation of the G
and Gγ polypeptides. It is interesting to note that G translation was more sensitive to
PhLP1 knockdown than G translation despite the fact that PhLP1 is known to
interact with nascent G but not nascent G (Lukov et al., 2005). In fact, G
translation was inhibited by PhLP1 knockdown to the same degree in the presence or
absence of G co-expression, whereas G translation was only sensitive to PhLP1
knockdown when Gγ was co-expressed (Fig. 2-2). These observations suggest that
PhLP1 contributes specifically to the translation of Gγ. To achieve this specificity,
some part of the mRNA or amino acid sequence of Gγ must be recognized and
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Figure 2-5. PhLP1 knockdown does not affect Gγ and G degradation and aggregation.
HEK-293 cells were treated with PhLP siRNA for 24 hrs and then transiently transfected with FLAG-G1
and HA-Gγ2. After 48 additional hrs, degradation experiments (A and B) were initiated by pulsing the cells
with 35S-methionine for 10 min and then chasing with unlabeled methionine and cycloheximide for the
indicated times. Cells were then lysed and immunoprecipitated with anti-HA for Gγ (A) or anti-FLAG for
G (B). Immunoprecipitates were separated by SDS-PAGE and radioactive Gγ or G bands were visualized
and quantified on a phosphor imager. Data points represent the average ± the standard error from three
experiments. Lines represent a non-linear least squares fit of the data to a first order rate of degradation
equation. Representative gels are shown below the graphs.
Aggregation experiments (C and D) were initiated by pulsing the cells with 35S-methionine for 25 min,
lysing the cells and pelleting insoluble material. The initial cell pellet was resuspended in 0.5% SDS for
SDS-PAGE analysis. The corresponding supernatant was immunoprecipitated with anti-HA for Gγ (C) or
anti-FLAG for G (D). The initial cell pellet, the immunoprecipitate (IP) and the supernatant after
immunoprecipitation were all subjected to SDS-PAGE and radioactive bands were visualized on a phosphor
imager. Gels shown are representative of at least three experiments.

translation inhibited in the absence of PhLP1. Translational initiation of RNA
transcipts is often controlled by their 5′ and 3′ UTRs (Dever, 2002; Hentze et al.,
2007).
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Figure 2-6. PhLP1 depletion has no effect on G or G mRNA levels.
HEK-293 cells were treated with PhLP1 or control siRNA for 24 hrs and then transiently
transfected with HA-G2 and FLAG-G1. After an additional 48 hrs, the cells were lysed, total
RNA was isolated, and the mRNA was reverse transcribed. The resulting cDNA was used as a
template for quantitative RT-PCR with G2 and G1 specific probes. The RT-PCR data were
normalized to the control siRNA values. Bars represent the average ± the standard error from three
experiments.

However, in these experiments the 5′ and 3′ UTRs of Gγ come from the expression
vector and are exactly the same as the GST construct whose translation was
unaffected by PhLP1 depletion. Thus, it is unlikely that the UTRs provide the
observed specificity. Sequences within the coding region of the mRNA transcript
could provide the observed specificity, but this is uncommon (Hentze et al., 2007).
Another way to specifically control Gγ translation would be to recognize the Nterminal amino acid sequence of Gγ as it emerges from the ribosome exit tunnel in
such a manner that translation stalls in the absence of PhLP1. Such is the case with
the signal recognition particle that detects N-terminal leader sequences of membrane
and secreted proteins co-translationally and inhibits the ribosome until the signal
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recognition particle binds its receptor and translocon in the endoplasmic reticulum
membrane (Halic and Beckmann, 2005; Shan and Walter, 2005; Walter and Blobel,
1981). This latter idea was tested by preparing a fusion construct of Gγ with GST
attached to its C-terminus. Various N-terminal truncations of the Gγ sequence were
prepared and tested for inhibition of translation in the absence of PhLP1 (Fig. 2-7A).
Fusing Gγ to GST made GST translation as sensitive to PhLP1 depletion as Gγ itself,
confirming that the G sequence was sufficient to confer PhLP1 sensitivity to
translation. Deletion of amino acids 1-10 of Gγ did not change the PhLP1 sensitivity.
However, deletion of amino acids 1-20 or 1-30 of Gγ created constructs whose
translation was totally insensitive to PhLP depletion. This result suggests that the
observed inhibition of Gγ translation upon PhLP depletion is mediated by a factor
that recognizes the sequence between residues 11-20 of Gγ as it leaves the ribosome
exit tunnel. To further test this possibility, the effect of PhLP1 knockdown on the
translation of a construct containing residues 11-20 of G fused to the N-terminus of
GST was also measured. PhLP1 knockdown decreased the rate of translation of this
construct by nearly the same amount as the full-length G-GST construct (33%
compared to 40%, respectively), indicating that the sequence between residues 11-20
of G was sufficient for PhLP1-dependent translation (Fig. 2-7B).
These data point to the amino acid sequence of Gγ 11-20 as the determining
factor in PhLP1-dependent translation inhibition. However, they do not rule out the
possibility that the Gγ mRNA nucleotide sequence of codons 11-20 is responsible.
To test this possibility, a Gγ construct was designed in which the nucleotide sequence
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of residues 11-20 was frame-shifted by inserting one nucleotide prior to codon 11 and
then removing one nucleotide after codon 20 to restore the reading frame at codon 21
(Fig. 2-7C). This modification retains the mRNA sequence of codons 11-20, but
scrambles the amino acid sequence. If the mRNA sequence was responsible for
PhLP1 sensitivity, the one nucleotide insertion would have little or no effect on
translation, but if the amino acid sequence were responsible, the scrambling of
residues Gγ 11-20 would make Gγ translation insensitive to PhLP1 depletion. The
data of Fig. 2-7C show that the rate of translation of this frame-shifted Gγ construct
was completely insensitive to PhLP1 knockdown, confirming that it is the amino acid
sequence of Gγ residues 11-20 that confers PhLP1-sensitivity to Gγ translation. The
intriguing interpretation of this finding is that the N-terminus of actively translating
Gγ somehow depends on PhLP1 to complete Gγ translation. If PhLP1 is absent, the
translation process stalls.
A potential insight into the mechanism of this apparent co-translational
regulation of Gγ synthesis is that residues 11-20 of Gγ form a coiled-coil interaction
with the N-terminus of the G subunit, making extensive contacts (Sondek et al.,
1996; Wall et al., 1995). This observation points to a role for G in the regulation of
Gγ translation. This possibility could be tested by making amino acid substitutions of
Gγ in the 11-20 sequence that disrupt its coiled-coil interaction with
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Figure 2-1. Residues 11-20 of G mediate the inhibitory effects of PhLP1 knockdown.
A) The effect of PhLP1 depletion on the translation of Gγ2-GST constructs with N-terminal Gγ2
truncations is shown. A schematic of the constructs used in this experiment is found about the
graph. The N-terminus of each construct was capped by an HA tag and a FLAG sequence was
used as a linker between G2 and GST as shown in the diagram. HEK-293T cells were treated
with PhLP siRNA for 24 hrs and then transiently transfected with the Gγ2-GST constructs as
indicated. After 72 additional hrs, the cells were pulsed for 35 min with [35S] methionine and the
fusion proteins were immunoprecipitated with an anti-HA antibody. Nascent Gγ2-GST in the
immunoprecipitates was quantified as in Fig. 2-1. Bars represent the average ± the standard error
from three experiments and a representative gel is shown below the graph. B) The effect of
PhLP1 depletion on the translation of a fusion construct of G residues 11-20 and GST is shown.
A schematic of the construct is found about the graph. HEK-293T cells were treated with siRNA,
transfected with this construct and translation was measured as in Fig.2-2. Data points represent
the average ± the standard error from three experiments and a representative gel is shown below
the graph. C) The effect of PhLP1 depletion on the translation of a Gγ construct in which a
frameshift (FS) was introduced into residues 11-20 is shown. The Gγ 11-20 frameshift was
created by adding a single nucleotide to the 5′ end of codon 11 of the Gγ ∆1-10/GST construct to
shift the reading frame and a single nucleotide was removed from the 3′ end of codon 20 to
restore the correct reading frame at residue 21. HEK-293T cells were treated with PhLP1 siRNA,
transfected with this construct and translation was measured as in Fig.2-2. Data points represent
the average ± the standard error from three experiments and a representative gel is shown below
the graph. D) The effect of PhLP1 depletion on the translation of a Gγ construct in which leucine
residues L15 and L19 from the Gγ ∆1-10/GST construct were substituted with glutamate is
shown. These substitutions disrupt the hydrophobic interaction between L15 and L19 of Gγ (red
dotted spheres) and residues A11 and L14 of G (blue dotted spheres) that contribute to the
coiled-coil interaction between the N-termini of Gγ (red) and G (blue). HEK-293T cells were
treated with PhLP1 siRNA, transfected with this construct and translation was measured as in
Fig.2-2. Data points represent the average ± the standard error from three experiments and a
representative gel is shown below the graph. The ribbon diagram was made from the Gi1γ2 Xray crystal structure (PDB ID: 1GP2) (Wall et al., 1995) using PyMol.

G and measure the effect of PhLP1-depletion on this Gγ variant. Leucines 15 and
19 of Gγ2 are conserved residues that make extensive contacts with G1 in the
coiled-coil (Wall et al., 1995) (Fig. 2-7D). Consequently, these residues were
substituted with glutamate, and the effect of PhLP1 depletion on the translation of the
GγL15E/L19E variant was measured. The rate of translation of the variant was
completely insensitive to PhLP1 knockdown (Fig. 2-7D), indicating that the coiledcoil interaction between the N-terminal regions of G and Gγ is necessary to elicit
stalling of Gγ translation in the absence of PhLP1.
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To further explore the role of G in Gγ translation, the effects of both cellular
depletion and over-expression of G on Gγ translation were measured without
changing the endogenous levels of PhLP1. Interestingly, siRNA-mediated G
depletion resulted in a significant increase in the rate of Gγ translation (Fig. 2-8A),
the opposite of what was observed with PhLP1 knockdown. Likewise, the overexpression of G caused a decrease in Gγ translation (Fig. 2-8B). These reciprocal
effects of G lead to the unexpected conclusion that the association of G with Gγ
must inhibit the rate of Gγ translation.

Figure 2-2. Effects of G knockdown and over-expression on the rate of G synthesis.
HEK-293T cells were treated with or without an siRNA targeting both G1 and G2 for 24 hrs and
then transiently transfected with HA-tagged Gγ2. After 72 additional hrs, the rate of Gγ translation
was measured as in Fig.2- 1. Data points represent the average ± the standard error from three
experiments. Error bars that are not visible are smaller than the symbol. A representative gel is
shown below the graph. B. HEK-293T cells were transiently transfected with HA-Gγ and either
G or a GST control. After 48 hrs, the cells were pulsed for 35 min with [35S] methionine and Gγ
translation was measured as in Fig.2-2. Bars represent the average ± the standard error from three
experiments and a representative gel is shown below the graph.

46

The results presented thus far point to a unique co-translational mechanism for
the regulation of Gγ synthesis in which formation of the N-terminal coiled-coil with
G stalls Gγ translation on the ribosome, while PhLP1 somehow unblocks the stalled
ribosome and allows translation to continue. For this regulation to occur, G must be
able to interact with the N-terminus of Gγ as it exits the ribosome. However, G is
not free in the cytosol prior to its association with Gγ but is bound to CCT (Lukov et
al., 2006; Wells et al., 2006). Interestingly, CCT has been previously shown to
interact co-translationally with nascent polypeptides on actively translating ribosomes
(Etchells et al., 2005; McCallum et al., 2000). Thus, it is possible that a ribosome
associated G-CCT complex could interact with the nascent Gγ and stall Gγ
translation. This idea is attractive because it also provides a means for PhLP1 to
unblock Gγ translation. PhLP1 has been shown to release G from CCT and permit
its subsequent association with Gγ (Lukov et al., 2006; Lukov et al., 2005). By
releasing G, PhLP1 may relieve its inhibition of Gγ synthesis. This hypothesis
predicts that PhLP1 and CCT would be associated with actively translating
ribosomes. To test this prediction, polysomes were isolated from cell extracts by
sucrose gradient centrifugation and were immunoblotted for the presence of PhLP1
and CCT. Both were found in significant amounts in the high density polysomal
fractions on the sucrose gradient (Fig. 2-9). The 60S ribosomal protein L23 was also
found in these same fractions, confirming that they contained ribosomes.
Pretreatment of cells with puromycin, an antibiotic that blocks translation and
dissociates polysomes into 40S and 60S ribosomal subunits (Blobel and Sabatini,
1971), resulted in a nearly complete shift of PhLP1 and CCT to the low density
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cytosolic fractions, while L23 shifted to intermediate fractions corresponding to the
migration of the 60S subunit as expected (Fig. 2-9). These results demonstrate that
PhLP1 and CCT are associated with polysomes and could thus interact cotranslationally with Gγ.

Figure 2-3. Association of PhLP1 and CCT with polysomes.
Binding of PhLP1 and CCT to polysomes was measured by sucrose gradient centrifugation. HEK-293
cells were incubated with or without puromycin (P), a translation inhibitor that disrupts polysomes, and
then extracted with detergent. Cell lysates were separated by high speed centrifugation through 10-70%
sucrose gradients. Fractions were collected from the top to bottom of the gradient and immunoblotted for
PhLP1, CCT or the 60S ribosomal protein subunit RPL23. Results are representative of three separate
experiments.

Discussion
For many years since the discovery of the Gγ complex, a question has
persisted regarding how the two nascent polypeptides are brought together when
neither of them can form a stable structure on their own. Recent work has shown that
CCT and PhLP1 are essential chaperones in the folding of G and in its subsequent
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association with Gγ (Humrich et al., 2005; Knol et al., 2005; Lukov et al., 2006;
Lukov et al., 2005). CCT binds nascent G and assists in the formation of the G
seven-bladed -propeller structure (Lukov et al., 2006; Wells et al., 2006). PhLP1
associates with G in the CCT folding cavity and catalyzes the release of G from
CCT and its subsequent interaction with Gγ (Lukov et al., 2006; Lukov et al., 2005).
However, current data provide little insight into the mechanism by which Gγ
associates with G. It is clear that Gγ does not form its high affinity complex with
G in the CCT folding cavity because no interaction of Gγ with G-CCT complexes
has been observed (Lukov et al., 2006; Wells et al., 2006). It seems likely that Gγ
only makes full contact with G after PhLP1 has released G from CCT. Once
released, Gγ can readily associate with G bound to PhLP1 because the Gγ binding
site on G does not overlap the PhLP1 binding site (Gaudet et al., 1996). However,
little is known about the status of Gγ prior to its assembly with G. One report has
shown that Gγ interacts with the J-domain containing chaperone DRiP78 (Dupre et
al., 2007b), and siRNA-mediated depletion of DRiP78 reduced Gγ dimer formation,
suggesting that DRiP78 is involved in Gγ assembly.
The results presented here point to a novel co-translational mechanism of Gγ
assembly. The data show that the rate of Gγ translation is sensitive to PhLP1 activity
in the cell. Cellular depletion of PhLP1 by siRNA or over-expression of a dominantnegative PhLP ∆1-75 variant, which both block Gγ assembly (Lukov et al., 2005),
reduced the rate of Gγ translation ~ 2-fold. This effect of PhLP depletion was
dependent on the ability of the N-terminus of Gγ to form its coiled-coil interaction
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with the N-terminus of G. Moreover, siRNA-mediated depletion of G enhanced
the rate of Gγ translation and over-expression of G decreased Gγ translation. These
results lead to the unexpected conclusion that formation of the coiled-coil interaction
between G and Gγ inhibits the rate of Gγ translation. To inhibit translation, this
interaction must occur co-translationally which requires the G-CCT complex to be
associated with translating ribosomes. Indeed CCT and PhLP1 were both found
associated with polysomes, making possible a co-translational interaction between G
and G on the ribosome.
A model for PhLP1-mediated co-translational Gγ assembly that is consistent
with all the current data is depicted in Fig. 2-10. In this model, the Gγ N-terminus
associates with the N-terminus of G in the CCT folding cavity forming the coiledcoil interaction as Gγ emerges from the ribosome exit tunnel. This interaction stalls
further translation of the Gγ mRNA transcript until PhLP1 is available to release G
from CCT and relieve the inhibition. Once G is released, translation continues and
the C-terminal amino acids of Gγ find their contacts along the surface of the G
propeller opposite the PhLP1 binding site as they emerge from the exit tunnel.
There are several advantages to a co-translational mechanism for Gγ
assembly. First, Gγ makes extensive hydrophobic interactions with G all along its
entire 70 amino acid length. If Gγ were synthesized and released into the cytosol
where the total protein concentration is high, the likelihood of Gγ finding G and
forming the Gγ dimer prior to its aggregation with other proteins would be very low.
Second, the binding of Gγ to chaperones like DRiP78, may make G dimer
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formation difficult. The efficiency of Gγ assembly from chaperones could be low
because of the numerous hydrophobic contacts with the chaperone that would need to
be broken and then reformed with G. Third, by assembling the Gγ dimer cotranslationally, the hydrophobic amino acids of Gγ would associate immediately with
their sites on G as they emerged from the exit tunnel, avoiding problems with
aggregation or transfer from chaperones.

Figure 2-4. Model of PhLP1-mediated co-translational assembly of Gγ with G.
The model depicts the proposed translational inhibition of Gγ as its N-terminus emerges from the
ribosome and forms a coiled-coil interaction with the N-terminus of G in the CCT complex. Gγ
translation is stalled until PhLP1 interacts with G and releases it from CCT. In the presence of PhLP1,
Gγ translation resumes and the nascent Gγ interacts co-translationally with G, forming the Gγ dimer.
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There are two intriguing questions raised by these results. First, why would
Gγ translation stall in the presence of its G binding partner? If anything, one would
predict that Gγ translation would be accelerated by G. The reason for stalling
appears to be the need to wait for PhLP1 to associate with the G-CCT complex and
release G. The inability of Gγ to form its high affinity complex with G on CCT
(Lukov et al., 2006; Wells et al., 2006) indicates that most of the Gγ contacts on G
are masked by CCT. If Gγ translation were to continue before these contacts could be
made, then many hydrophobic residues of Gγ would be left exposed and subject to
aggregation or binding by chaperones of the degradative pathway (Kaganovich et al.,
2008). PhLP1 is the limiting factor. It is expressed at an ~4-fold lower concentration
than CCT (McLaughlin et al., 2002b), thus the cell would have many G-CCT
complexes not associated with PhLP1. These complexes would co-translationally
bind the N-terminus of nascent Gγ in the coiled-coil interaction and stall translation
until PhLP1 could associate with G and release it from CCT, freeing up the
hydrophobic contact sites for Gγ on G and allowing translation to resume. In this
manner, exposure of the hydrophobic residues of both G and Gγ would be
minimized.
The second question concerns the mechanism of stalling. How does
formation of the Gγ N-terminal coiled-coil with G cause Gγ translation to stall until
PhLP1 can release G from CCT? Insight can be gained from other examples of cotranslational ribosome stalling. In the case of the eukaryotic signal recognition
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particle (SRP), the signal peptide is recognized by the SRP54M domain at the exit
tunnel (Halic et al., 2006), which positions the SRP Alu domain in the elongation
factor binding site where it would inhibit elongation through steric hindrance (Halic
et al., 2004). It is possible that co-translational binding of the Gγ N-terminus to G in
the CCT complex positions CCT so that it blocks elongation factor binding. The
distance between the exit tunnel and the elongation factor binding site is 12 nm (Halic
et al., 2004) while the diameter of the CCT complex is 15 nm (Llorca et al., 1999).
Thus, the CCT complex is sufficiently large to block the elongation factor binding
site if positioned correctly. Alternatively, co-translational formation of the coiledcoil between nascent Gγ and G may cause a conformational change in the nascent
Gγ that is transferred up the exit tunnel and into the peptidyl transferase center,
disrupting translation. An example of this type of translational inhibition is seen with
the TnaC leader peptide of the E. coli typtophanase operon, in which high
concentrations of tryptophan cause changes in the interactions between the leader
peptide in the ribosome exit tunnel that disrupt the peptidyl transferase center (Seidelt
et al., 2009). Additional structural work will be required to determine the molecular
details of G-mediated stalling of Gγ translation.
In summary, this work outlines an elegant mechanism that links translation of
the Gγ subunit to formation of the Gγ dimer, bringing together the unstable G and
Gγ polypeptide chains in a way that avoids aggregation or degradation of the Gγ
subunit. It will be of interest to determine if other obligate dimers like Gγ are also
co-translationally assembled.
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CHAPTER 3
ROLE OF PHLP2 AND PHLP3 IN ACTIN AND TUBULIN FOLDING IN
MAMMALIAN CELLS
Summary
PhLP2 and PhLP3 are members of the phosducin gene family that are known to
interact with the cytosolic chaperonin complex (CCT). In so doing, they may regulate
CCT-mediated actin and tubulin folding. Their functional role in CCT-mediated actin
and tubulin folding is different in vitro and in vivo. While in vitro experiments
suggest a negative regulatory role, in vivo studies in yeast suggest otherwise. The
results of this study show that PhLP2A is not involved in actin, -tubulin and tubulin folding, while PhLP3 may contribute to actin folding, but not -tubulin or tubulin folding. These results indicate very different roles for PhLP2A and PhLP3 in
human cells compared to their proposed roles in yeast.
Introduction
To reach their native three dimensional state, significant numbers of proteins
rely on a group of proteins called chaperones (Hartl and Hayer-Hartl, 2002). An
intriguing class of oligomeric, high-molecular-weight chaperones with the unique
ability to fold some cytosolic proteins that cannot be folded by simpler chaperone
systems are called chaperonins (Frydman, 2001). This unique group of chaperones
consists of two-ring assemblies with a central cavity where substrate polypeptides
interact and are protected from the cytosolic milieu until they can reach their native
state (Bukau and Horwich, 1998; Gutsche et al., 1999). In eukaryotes, CCT
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(chaperone-containing TCP1, also called TRiC, TCP-1 ring complex) was initially
proposed to fold only actin and tubulin, but many other substrates have recently been
discovered (Dekker et al., 2008; Thulasiraman et al., 1999; Yam et al., 2008),
including a class of proteins containing WD 40 repeats, a 40 amino acid repeat ending
in a tryptophan-aspartic acid (WD) sequence (Valpuesta et al., 2002). Several proteins
including the phosducin-like proteins have been reported to bind mammalian and yeast
CCT (Lukov et al., 2005; Martin-Benito et al., 2004; McLaughlin et al., 2002a;
Stirling et al., 2006). In so doing, they modulate the folding and ATPase activities of
CCT.
In humans three phosducin gene family members form ternary complexes with
CCT and it substrates (Willardson and Howlett, 2007). These include PhLP1,
PhLP2A, PhLP2B, PhLP3, while the original member of the gene family phosducin
does not bind CCT (Willardson and Howlett, 2007). Of the two PhLP2 genes in
humans and mice, PhLP2A is a ubiquitously expressed phosphoprotein (Wilkinson et
al., 2004), while PhLP2B has been reported to only be expressed in male and female
germ cells undergoing meiotic maturation (Lopez et al., 2003). Just like PhLP1,
PhLP2A and PhLP3 have been shown to inhibit CCT-actin and CCT-tubulin folding
in in vitro translation systems (Stirling et al., 2006; Stirling et al., 2007). The ATPase
activity of CCT in actin and tubulin folding is also inhibited by PhLP3 (Stirling et al.,
2006; Stirling et al., 2007). However, in vitro and in vivo experiments to elucidate the
function of PhLP2A suggest that it inhibits CCT-actin folding while its yeast
orthologue PLP2 positively regulates CCT and actin function (Stirling et al., 2007).
This positive regulatory role of yeast PLP2 was confirmed by an in vitro yeast CCT55

ACT1 folding assay in which PLP2-CCT-ACT1 complexes yielded 30-fold more
native actin than CCT-ACT1 complexes (McCormack et al., 2009). Like PhLP2,
there are also discrepancies in the function of PhLP3 in the folding of cytoskeletal
proteins actin and tubulin. While in vivo genetic analysis in yeast suggest a positive
role of PhLP3 in tubulin folding (Lacefield and Solomon, 2003; Ogawa et al., 2004;
Stirling et al., 2006), in vitro -tubulin folding assays suggest otherwise (Stirling et al.,
2006). Human PhLP3 perturbs actin or -tubulin folding in vitro, while its yeast
orthlogue PLP1 appears to coordinate the proper biogenesis of actin and tubulin with
prefoldin (Stirling et al., 2006).
The current study was conducted to further investigate the effect of PhLP2A
and PhLP3 in actin and tubulin folding in mammalian cells. The results show that
PhLP2A is not involved in actin, -tubulin and -tubulin folding, while PhLP3 may
contribute to actin folding, but not -tubulin or -tubulin folding. These results
indicate very different roles for PhLP2A and PhLP3 in human cells compared to their
proposed roles in yeast.
Experimental Procedures
Cell Culture - HEK293T cells were cultured in DMEM/F-12 (50/50 mix)

growth media supplemented with L-glutamine, 10% fetal bovine serum and 15 mM
HEPES (Hyclone Scientific). In order to maintain active growth, cells were
subcultured regularly but not beyond 15 passages.
RNA Interference - Small interfering RNAs (siRNAs) were chemically

synthesized (Dharmacon) to target nucleotides 345-365 of human PhLP1 (Lukov et
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al., 2005), nucleotides 181-199 of human PhLP2A, nucleotides 989-1007 of human
PhLP3 and nucleotides 172-192 of human CCTζ-1 (Grantham et al., 2006). All the
oligonucleotides had 3′dTdT overhangs. HEK293T cells were cultured in 12 well
plates to 40-65% confluency. Cells were then transfected with the appropriate siRNA
at 100 nM final concentration using Oligofectamine (Invitrogen) (Lukov et al., 2005).
Cells were harvested for subsequent immunoprecipitation experiments 96 hours later.
To assess the percent knockdown of specific proteins, 15 μg of cell lysate were
immunoblotted with an anti-PhLP1 antiserum (Thulin et al., 1999) , an anti-CCTζ
antibody (Santa Cruz Biotechnology), an anti-PhLP2A antiserum prepared in rabbits
against amino acids I216EDVLLSSVRRSVLMKRDSD235, and an anti-PhLP3
antibody prepared in rabbits against the full-length PhLP3 protein to determine the
extent of knockdown.
Transient Transfections - HEK 293T cells were treated with siRNA and then

transfected 24 hrs later with 1.0 µg of C-terminal myc-tagged PhLP1, PhLP2A, or
PhLP3; or C-terminal Flag-tagged tubulin co-factor A or tubulin co-factor B as
indicated using Lipofectamine Plus Reagent according to the manufacturer’s protocol
(Invitrogen). The cells were used in subsequent applications after 72 hrs. For overexpression experiments not involving siRNA treatment, HEK 293T were plated in 12
well plates so that they were 70-80% confluent the next day. The cells were then
transfected with 1.0 µg cofactor A-Flag, cofactor B-Flag, PhLP1-myc, PhLP2A-myc,
14-3-3ε-Flag, PhLP3-myc and empty vector (pcDNA3.1 (+)) as indicated. The cells
were harvested for subsequent applications after 48 hrs.
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Radiolabel Pulse-Chase Assay - Vector transiently transfected and siRNA-

treated HEK293T cells in 12-well plates were washed and incubated in 1000 µl of
methionine free media (Mediatech, Inc) supplemented with 4 mM L-glutamine
(Sigma), 0.063g/L L-cystine dihydrochloride (USB) and 10% dialyzed fetal bovine
serum (Hyclone). The media was discarded and 400 µl of new media supplemented
with 200 µCi/ml radiolabeled L-[35S] methionine (Amersham Biosciences) was
added. The cells were then incubated at 23oC for 10 min. to incorporate the [35S]
methionine into newly synthesized proteins. After the pulse phase, the cells were
washed and incubated at 23oC for 15 min. in 2 ml of media supplemented with 4 mM
non-radiolabeled L-methionine and 4 µM cycloheximide (Sigma) to stop the [35S]
methionine incorporation. Following the chase period the cells were harvested for
immunoprecipitation experiments.
Immunoprecipitation - Pulse-chase labeled HEK 293T cells were washed

three times with phosphate-buffered saline (PBS, Fisher) to remove free 35Smethionine (Perkin Elmer) and solubilized in actin IP buffer (20 mM HEPES pH 7.4,
50 mM KCl, 1 mM DTT, 0.2 mM CaCl2, 0.5% NP-40, 4 µM cycloheximide, 1 mM
PMSF, 40 mM glucose and 6 μl/ml protease inhibitor cocktail per mL (Sigma)) in the
case of actin folding. Cells were solubilized in tubulin IP buffer (PBS, pH 7.4, 0.5%
NP-40 (Sigma), 0.6 mM PMSF, 6 μl/ml protease inhibitor cocktail per mL buffer
(Sigma)) in the case of tubulin folding. The lysates were passed through a 25-gauge
needle 10 times and centrifuged at 14,000 rpm for 10 min. at 4ºC in an Eppendorf
microfuge. The protein concentration for each sample was determined using the
BCA Protein Assay reagent (Thermo Scientific) in the case of actin folding or
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Coomassie Plus Protein Assay reagent (Thermo Scientific) in the case of tubulin
folding and equal amounts of protein were used in the subsequent
immunoprecipitations. 160 μg of total protein from the clarified lysates were
incubated for 1 hour at 4°C in the presence of DNase I-affigel beads prepared as
described previously (Rosenblatt et al., 1995) in the case of actin folding, or for 30
min. at 4°C with 2 μg anti-Flag (clone M2, Sigma) followed by an additional 30 min.
at 4°C with 25 μl of a 50% slurry of Protein A/G Plus agarose (Santa Cruz
Biotechnology) in the case of tubulin folding. Samples were centrifuged for 2 min at
4,000 rpm in an Eppendorf microfuge and washed 3 times with 1 ml of IP buffer.
The immunoprecipitated proteins were solubilized in SDS sample buffer and resolved
on a 10% Tris-glycine-SDS gel. The gels were dried on Whatman filter paper for
subsequent radioactivity measurements. Gels were visualized with a Storm 860
phosphor imager and the band intensities were quantified using the Image Quant
software (GE Healthcare).
For 14-3-3 co-immunoprecipitation experiments, HEK-293 cells in 6-well
plates were transfected with 1.0 µg of the indicated PhLP-myc cDNAs along with 1.0
µg of C-terminal Flag tagged 14-3-3ε as described above. The 14-3-3ε was
immunoprecipitated as described above and immunoblotted for the indicated mycPhLP isoforms.
Results
To better elucidate the function and physiological role of human PhLP1,
PhLP2A and PhLP3 in CCT-mediated actin and tubulin folding in mammalian cells,
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the effects of their siRNA-mediated knockdown on the folding of -actin, -tubulin
and -tubulin were measured in HEK-293 cells. The siRNA treatment resulted in 7080% depletion of the endogenous PhLP1, PhLP2A and PhLP3 (Fig. 3-1 A-C). The
effects of this depletion on nascent -actin folding was measured by pulsing the cells
with [35S] methionine and then chasing with unlabeled methionine and
cycloheximide, blocking further translation and [35S] incorporation into proteins.
After the chase period, the amount of nascent -actin synthesized and properly folded
during the pulse-chase was determine by the binding of the [35S] labeled actin to
DNase I immobilized on agarose beads. It has been previously shown that native
monomeric -actin binds to DNase I with high affinity, and this method has been
used to measure actin folding in cells (Farr et al., 1997). Interestingly, PhLP1 and
PhLP2A depletion had no effect on -actin folding (Fig. 3-1 E-F) while PhLP3
depletion showed a consistent 40% decrease in actin folding (Fig. 3-1G). As a
positive control, the effect of CCTζ knockdown on actin folding was also measured.
-actin folding is very sensitive to CCT depletion given the fact that CCT is required
for actin folding (Grantham et al., 2006) . CCTζ knockdown resulted in a 60%
depletion of CCTζ (Fig. 3-1 D) and a similar reduction in CCT complexes (Howlett et
al., 2009) . Accordingly, a 60% reduction in -actin folding was also observed,
indicating that this method of measuring actin folding was accurate. Thus, the
observed decrease in -actin folding upon PhLP3 depletion suggests a positive
regulatory role for PhLP3 in -actin folding.
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Figure 3-1. Effect of siRNA-mediated knockdown of PhLP isoforms on actin folding.
HEK-293T cells were treated with control siRNA or siRNA specific to PhLP1 (A), PhLP2A (B),
PhLP3 (C) or CCTζ (D) as described in Experimental Procedures. Cell extracts were
immunoblotted and quantified to determine the efficiency of the siRNA knockdown. The effect of
these knockdowns on actin folding was determined by measuring the binding of nascent actin to
DNase I beads in an [35S] pulse-chase experimental format as described in Experimental Procedures.
In each experiment, the amount of actin bound to the DNase I beads was calculated as a fraction of
that bound in the scrambled siRNA control. Bars represent the average ± standard error from at
least three experiments. Representative gels are shown below the graphs.

To further assess the effects of PhLPs on actin folding, PhLP1, PhLP2A or
PhLP3 were over-expressed in HEK 293T cells and the effects on -actin folding
were again measured. Over-expression of each of these PhLPs caused between 4060% inhibition of -actin folding (Fig. 3-2). It was previously reported that the
decrease in actin folding due to PhLP1 was a result of direct competition with binding
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substrates of CCT (McLaughlin et al., 2002a). Moreover, inhibition of -actin
folding by PhLP2A using a mammalian in vitro translation and folding assay has also
been reported (McCormack et al., 2009). It is not clear why both depletion and overexpression of PhLP3 would inhibit -actin folding. Perhaps the endogenous levels of
PhLP3 are optimal to assist in -actin folding and excess PhLP3 somehow interferes
with the folding process (see Discussion).

Figure 3-2. Effect of over-expression of PhLP isoforms on actin folding.
HEK-293T cells were transfected with cDNA constructs for PhLP1, PhLP2A, PhLP3 or an empty
vector control along with a Flag -actin construct as described in Experimental Procedures. The
effect of these over-expressions on actin folding was determined by measuring the binding of the
over-expressed and endogenous actin to DNase I beads in an [35S] pulse-chase experimental format as
in Fig. 3-1. Bars represent the average ± standard error from at least three experiments. A
representative gel is shown below the graph with the upper band corresponding to Flag-tagged -actin
and the lower band corresponding to endogenous -actin. Both bands were quantified in the analysis.
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A proteomic screen for PhLP2A binding partners had previously suggested an
interaction with 14-3-3 proteins (B.M.W. unpublished observations). 14-3-3s are
abundant proteins known to bind phospho-serine and phospho-threonine residues and
modulate protein function in a phosphorylation-dependent manner (Yaffe, 2002) . To
confirm this interaction, a co-immunoprecipitation experiment was performed in
which each PhLP family member was over-expressed in HEK-293T cells along with
14-3-3ε. After immunoprecipitating the 14-3-3ε, the co-immunoprecipitation of
PhLPs was determined by immunoblotting. Only PhLP2A was found in the 14-3-3ε
immunoprecipitate (Fig. 3-3 A). The interaction was investigated further by focusing
on the C-terminus of PhLP2A, which has two phosphorylation consensus sites for the
kinase CK2 at S234 and S236, and phosphorylation of these sites has been shown in
global phospho-proteome screens (Dephoure et al., 2008; Kim et al., 2005) . A
truncation of the C-terminal residues 233-239 resulted in a PhLP2A variant with
significantly reduced 14-3-3ε binding (Fig. 3-3 B), indicating that part of the
interaction between PhLP2A and 14-3-3ε occurs at the C-terminus. The significance
of the PhLP2A/14-3-3ε interaction was further investigated by measuring the effect of
14-3-3ε over-expression on -actin folding. In the absence of PhLP2A, 14-3-3ε overexpression had no effect on -actin folding, but in the presence of PhLP2A, 14-3-3ε
relieved the inhibition caused by PhLP2A (Fig. 3-3 C). This effect was dependent on
the C-terminus of PhLP2A because inhibition of -actin folding by the PhLP2A
∆233-239 variant was not relieved by 14-3-3ε (Fig. 3-3 C).
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Figure 3-3. Effect of the PhLP2A/14-3-3 interaction on actin folding.
A) The binding of 14-3-3ε to PhLP isoforms was determined by co-immunoprecipitation. HEK293T cells were transfected with cDNA constructs for the indicated PhLP isoforms, each with a Cterminal myc epitope tag, along with a C-terminal Flag-epitope tagged 14-3-3ε. The 14-3-3ε was
immunoprecipitated with an antibody to the Flag tag and the presence of PhLP isoforms in the coimmunoprecipitate was detected by immunoblotting with an antibody to the myc tag. B) The coimmunoprecipitation of a PhLP2A ∆233-239, a variant missing the last 7 amino acids, was
compared to that of full length PhLP2A. Bars represent the average ± standard error from at least 3
experiments. C) The effect of 14-3-3ε on the inhibition of -actin folding by PhLP2A or the
PhLP2A ∆233-239 variant is shown. -actin folding was measured as in Fig. 3-2. Bars represent the
average ± standard error from at least three experiments. A representative gel is shown below the
graph with the upper band corresponding to Flag-tagged -actin and the lower band corresponding
to endogenous -actin. Both bands were quantified in the analysis. Panels A and B were from work
done by Amy Gray.
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These results are consistent with the finding that replacement of the C-terminus of
PhLP2A with the highly divergent sequence from the C-terminus of PLP2 from yeast
also relieved the inhibition of -actin folding in rabbit reticulocyte lysates
(McCormack et al., 2009). These results suggest that PhLP2A may be regulating actin folding in a 14-3-3ε dependent manner.
It has been hypothesized that different PhLPs favor the folding of different
CCT substrates (Willardson and Howlett, 2007). To further test this notion, the
effects of PhLP1, PhLP2A and PhLP3 on the folding of two additional important
CCT substrates, - and -tubulin, were also determined. To perform these
experiments in cells, new tubulin folding assays were developed. Previous assays
measured the incorporation of nascent - and -tubulin into microtubules (Yaffe et
al., 1992) . This assay was cumbersome and not sufficiently sensitive for the small
scale cell culture format necessitated by siRNA knockdown methods. Therefore a
new assay was developed which takes advantage of the binding of -tubulin to
tubulin co-factor B upon release from CCT and the binding of -tubulin to tubulin cofactor A upon release from CCT. These co-factors assist in the formation of the 
tubulin dimer after the tubulin protomers are folded by CCT (Lopez-Fanarraga et al.,
2001) . These assays followed a similar work flow as the -actin folding assay,
except that after the pulse-chase period, nascent folded -tubulin was isolated by coimmunoprecipitation with over-expressed Flag-tagged co-factor B and nascent folded
-tubulin was isolated by co-immunoprecipitation with over-expressed Flag-tagged
co-factor A. In the case of -tubulin, siRNA depletion or over-expression of PhLP1,
65

PhLP2A or PhLP3 in HEK-293T cells had no effect on -tubulin folding (Fig.3- 4),
indicating that -tubulin folding is independent of these PhLPs in HEK-293T cells. In
the case with -tubulin, siRNA-mediated depletion of PhLP2A or PhLP3 seemed to
increase -tubulin folding, while over-expression of PhLP1, PhLP2A or PhLP3 had
little effect.

Figure 3-4. Effect of PhLP isoforms on -tubulin folding.
A) HEK-293T cells were treated with siRNA specific to PhLP1, PhLP2A, PhLP3 or a scrambled
siRNA control as indicated. After 24 hours, the cells were transfected with an N-terminal Flag
tagged co-factor B. After 72 additional hours, the binding of nascent-tubulin to co-factor B was
determined as a measure of -tubulin folding in a pulse-chase experimental format as described in
Experimental Procedures. In each experiment, the amount of nascent -tubulin bound to co-factor
B was calculated as a fraction of that bound in the scrambled siRNA control. Bars represent the
average ± standard error from at least three experiments. A representative gel is shown below the
blot. B) HEK-293T cells were transfected with the indicated PhLP cDNA constructs and after 48
hours, -tubulin folding was measured as described in panel A. In each experiment, the amount of
nascent -tubulin bound to co-factor B was calculated as a fraction of that bound in the empty
vector control. Bars represent the average ± standard error from at least three experiments. A
representative gel is shown below the blot.
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However, the -tubulin folding results are suspect because the binding of -tubulin
to co-factor A was weak, resulting in faint -tubulin bands in the coimmunoprecipitate that were difficult to quantify and more importantly because
CCTζ depletion did not inhibit -tubulin folding as would be expected. Thus, it
appears that a different assay will need to be developed to measure -tubulin folding
accurately.

Figure 3-5. Effect of PhLP isoforms on -tubulin folding.
A) HEK-293T cells were treated with siRNA specific to CCTζ, PhLP1, PhLP2A, PhLP3 or a scrambled
siRNA control as indicated. After 24 hours, the cells were transfected with an N-terminal Flag tagged cofactor A. After 72 additional hours, the binding of nascent -tubulin to co-factor A was determined as a
measure of -tubulin folding in a pulse-chase experimental format as described in Experimental
Procedures. In each experiment, the amount of nascent -tubulin bound to co-factor A was calculated as a
fraction of that bound in the scrambled siRNA control. Bars represent the average ± standard error from at
least three experiments. Representative gels are shown below the blot. B) HEK-293T cells were
transfected with the indicated PhLP cDNA constructs and after 48 hours, -tubulin folding was measured
as described in panel A. In each experiment, the amount of nascent -tubulin bound to co-factor A was
calculated as a fraction of that bound in the empty vector control. Bars represent the average ± standard
error from at least three experiments. Representative gels are shown below the blot. This Figure is from
work done by Amy Gray.
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Discussion
Recent work has shown that all members of the Pdc gene family, except for
Pdc itself, form complexes with CCT and in so doing serve as modulators of CCTmediated protein folding. The key role of PhLP1 as a co-chaperone in the folding of
G and in the assembly of the Gγ dimer has been recently characterized (Lukov et
al., 2006; Lukov et al., 2005; Martin-Benito et al., 2004; McLaughlin et al., 2002a).
The roles of PhLP2 and PhLP3 in CCT-dependent protein folding are less clear.
Genetic studies of PhLP3 in S. cerevisiae and C. elegans suggest that PhLP3
participates in -actin and -tubulin biogenesis (Lacefield and Solomon, 2003;
Ogawa et al., 2004; Stirling et al., 2006). PhLP2A is essential for viability in S.
cerevisiae (Flanary et al., 2000), possibly as a co-chaperone in the folding of
cytoskeletal components such as -actin and -tubulin or essential cell cycle
components (McCormack et al., 2009; Stirling et al., 2006; Stirling et al., 2007).
While these reports have begun to define the physiological role of PhLP2 and PhLP3,
much is still unknown. In particular, there appears to be significant differences in
PhLP function between lower and higher eukaryotes. For example, the yeast
orthologue of PhLP2A, PLP2, greatly enhances -actin folding (McCormack et al.,
2009), while mammalian PhLP2A inhibits it, both in rabbit reticulocyte lysate in vitro
translation and folding assays (McCormack et al., 2009) and in HEK-293 cells (Fig.
3-2). Moreover, the yeast orthologue of PhLP3, PLP1, appears to enhance -tubulin
folding and inhibit -actin folding (Stirling et al., 2006), while the results reported
here suggest that in HEK-293T cells, endogenous PhLP3 enhances -actin folding
while having little or no effect on - or -tubulin folding (Figs. 3-1, 3-4 and 3-5).
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It is interesting to note that depletion and over-expression of PhLP3 both
inhibited -actin folding, though it is not clear why this is the case. It appears that the
endogenous level of PhLP3 in HEK-293 cells is carefully balanced for optimal actin folding. A possible explanation of this phenomenon comes from in vitro
experiments in which PhLP3 formed a ternary complex with -actin and CCT and
inhibited -actin folding. Perhaps the order of association of -actin and PhLP3 with
CCT is important in-actin folding. If -actin binds CCT first followed by PhLP3,
then efficient folding of -actin occurs. Such would be the case at endogenous levels
of PhLP3 in HEK-293T cells where -actin is in large excess. However, when
PhLP3 is over-expressed, it may begin to bind CCT before -actin and disrupt the
productive binding of -actin to CCT needed for folding. A similar mechanism may
be responsible for the inhibition of -actin folding upon over-expression of PhLP1
and PhLP2A. These PhLPs may also block productive -actin binding to CCT. The
difference between the effects of PhLP1 and PhLP2A compared to PhLP3 may be
that the former cannot form productive ternary complexes with -actin and CCT no
matter the order of binding.
An alternative explanation for the dual effects of PhLP3 on -actin folding
may lie in the fact that PhLP3 has been shown to inhibit the ATPase activity of CCT
(Stirling et al., 2006). This activity is essential for -actin release from CCT.
Perhaps excess PhLP3 slows the release of -actin from CCT and thereby decreases
the rate of -actin folding. Whatever the mechanism, it appears that PhLP3 does play
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a role in -actin folding in HEK-293T cells and further studies will be needed to
determine precisely what that role is.
The ability of 14-3-3 to relieve the inhibition of -actin folding by PhLP2A is
noteworthy. It has been shown previously that this inhibition is dependent on the Cterminal residues of PhLP2A (McCormack et al., 2009). The results presented here
show that 14-3-3 relieves the inhibition of -actin folding by binding to the Cterminus of PhLP2A. Binding of 14-3-3ε to PhLP2A has been shown to depend on
phosphorylation of S234 and S236 in this C-terminal region (Amy Gray unpublished
results). These findings add another layer of complexity to the regulation of CCTmediated protein folding by PhLPs. Not only do certain PhLPs favor the folding of
certain substrates and inhibit the folding of others, but it appears that this substrate
selection can be regulated by phosphorylation and 14-3-3 binding.
The apparent lack of effect of PhLPs on tubulin folding in HEK-293T cells is
surprising, given the evidence for a role of PhLP2A and PhLP3 in tubulin folding in
other organisms (Lacefield and Solomon, 2003; Ogawa et al., 2004; Stirling et al.,
2006). However, these results need to be verified in tubulin folding assays that are
sensitive to CCT knockdown. The binding of nascent -tubulin to co-factor B was
strong and clearly quantifiable bands were observed, but the effects of CCTζ
knockdown were not measured. In contrast, the binding of nascent -tubulin to cofactor A was weak and the bands were not easily quantifiable. Moreover, CCTζ
knockdown had little effect on the amount folded in this assay. Therefore, it is
unlikely that the binding of nascent -tubulin to co-factor A is a good measure of tubulin folding. Future experiments will address these issues. Perhaps the best
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solution is to measure the amount of nascent -tubulin bound to -tubulin in a similar
co-immunoprecipitation format. Whatever alternative assays are developed, they
should show a decrease in -tubulin folding upon CCTζ knockdown.
In summary, it appear that PhLP3 may assist in -actin folding in mammalian
cells and that PhLP1 and PhLP2A inhibit actin folding in favor of other CCT
substrates. In the case of PhLP1, G is its principal substrate, but the major
substrates for PhLP2A have yet to be identified. Understanding the effects of PhLPs
on tubulin folding in mammalian cells awaits the development and validation of
better folding assays.
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